| Q33769267 | "We do not bury dead livestock like human beings": Community behaviors and risk of Rift Valley Fever virus infection in Baringo County, Kenya |
| Q46309054 | 143 Rift Valley fever virus: A virus with potential for global emergence. |
| Q37572918 | A 3-year serological and virological cattle follow-up in Madagascar highlands suggests a non-classical transmission route of Rift Valley fever virus |
| Q40325815 | A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge. |
| Q27468917 | A Genome-Wide RNA Interference Screen Identifies a Role for Wnt/β-Catenin Signaling during Rift Valley Fever Virus Infection |
| Q36481559 | A Haploid Genetic Screen Identifies Heparan Sulfate Proteoglycans Supporting Rift Valley Fever Virus Infection |
| Q26315336 | A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep |
| Q36849904 | A Rift Valley fever atlas for Africa |
| Q33565904 | A Rift Valley fever risk surveillance system for Africa using remotely sensed data: potential for use on other continents |
| Q40817422 | A Rift Valley fever vaccine trial: 2. Serological response to booster doses with a comparison of intradermal versus subcutaneous injection |
| Q54942043 | A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targeting. |
| Q33316823 | A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. |
| Q27483604 | A SLOWLY SEDIMENTING INFECTIOUS COMPONENT OF RIFT VALLEY FEVER VIRUS |
| Q27480356 | A Shared Transcription Termination Signal on Negative and Ambisense RNA Genome Segments of Rift Valley Fever, Sandfly Fever Sicilian, and Toscana Viruses |
| Q28647232 | A Spatial Analysis of Rift Valley Fever Virus Seropositivity in Domestic Ruminants in Tanzania |
| Q35683872 | A Stochastic Model to Study Rift Valley Fever Persistence with Different Seasonal Patterns of Vector Abundance: New Insights on the Endemicity in the Tropical Island of Mayotte |
| Q38254408 | A Systematic Scoping Study of the Socio-Economic Impact of Rift Valley Fever: Research Gaps and Needs |
| Q40819945 | A blood meal analysis of engorged mosquitoes found in Rift Valley fever epizootics area in Kenya. |
| Q41025947 | A brain factor influencing the viability of neurotropic Rift Valley fever |
| Q40762623 | A comparative evaluation of methods for detecting the Rift Valley fever virus |
| Q40379142 | A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity |
| Q40110444 | A dynamic, climate-driven model of Rift Valley fever |
| Q34999859 | A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses |
| Q38192772 | A geographical information system-based multicriteria evaluation to map areas at risk for Rift Valley fever vector-borne transmission in Italy. |
| Q43046864 | A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion. |
| Q40186455 | A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep. |
| Q34717000 | A hierarchical network approach for modeling Rift Valley fever epidemics with applications in North America |
| Q40323874 | A mathematical model of Rift Valley Fever with human host |
| Q36480027 | A model for the coupling of the Greater Bairam and local environmental factors in promoting Rift-Valley Fever epizootics in Egypt |
| Q40197590 | A modeling approach to investigate epizootic outbreaks and enzootic maintenance of Rift Valley fever virus |
| Q37561593 | A need for One Health approach - lessons learned from outbreaks of Rift Valley fever in Saudi Arabia and Sudan |
| Q40287896 | A network-based meta-population approach to model Rift Valley fever epidemics |
| Q39196341 | A new mouse model reveals a critical role for host innate immunity in resistance to Rift Valley fever. |
| Q40053961 | A novel highly sensitive, rapid and safe Rift Valley fever virus neutralization test |
| Q38865387 | A novel indirect ELISA based on glycoprotein Gn for the detection of IgG antibodies against Rift Valley fever virus in small ruminants |
| Q38614847 | A novel system for identification of inhibitors of rift valley Fever virus replication. |
| Q39015060 | A possible route for the introduction of Rift Valley fever virus into Egypt during 1977. |
| Q39093729 | A preliminary report on an epidemic of Rift Valley Fever (RVF) in Egypt |
| Q33621078 | A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge |
| Q40538872 | A retrospective study of Rift Valley fever in Saudi Arabia. |
| Q28082904 | A review of mosquitoes associated with Rift Valley fever virus in Madagascar |
| Q40841428 | A rift Valley fever vaccine trial. I. Side effects and serologic response over a six-month follow-up |
| Q38962199 | A seroepidemiological study for Rift Valley fever virus in humans and domestic animals in Egypt |
| Q40840918 | A serological survey for Rift Valley fever antibody in food animals in Kaduna and Sokoto States of Nigeria. |
| Q40848420 | A serological survey of Rift Valley fever antibodies in the northern Sinai |
| Q37004283 | A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection |
| Q35027744 | A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs. |
| Q59335452 | A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice |
| Q34633954 | A spatially explicit metapopulation model and cattle trade analysis suggests key determinants for the recurrent circulation of rift valley Fever virus in a pilot area of madagascar highlands |
| Q37626719 | A statistical model of Rift Valley fever activity in Egypt |
| Q91960684 | A strand-specific real-time quantitative RT-PCR assay for distinguishing the genomic and antigenomic RNAs of Rift Valley fever phlebovirus |
| Q28607192 | A study of Rift Valley fever virus in Morogoro and Arusha regions of Tanzania - serology and farmers' perceptions |
| Q40746393 | A study of the effect of chemical inactivants on the epitopes of Rift Valley fever virus glycoproteins using monoclonal antibodies |
| Q26315341 | A survey of rift valley fever and associated risk factors among the one-humped camel (Camelus dromedaries) in Sudan |
| Q34487937 | A systematic review of Rift Valley Fever epidemiology 1931-2014. |
| Q34283868 | A temperature-limited assessment of the risk of Rift Valley fever transmission and establishment in the continental United States of America |
| Q41012883 | A variant of Rift Valley fever virus |
| Q35616459 | A ΩXaV motif in the Rift Valley fever virus NSs protein is essential for degrading p62, forming nuclear filaments and virulence |
| Q34244912 | AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis |
| Q40753140 | Ability of a mutagenized virus variant to protect young lambs from Rift Valley fever |
| Q40850399 | Abortion in vaccinated sheep and cattle after challenge with Rift Valley fever virus |
| Q33647696 | Absence of Evidence of Rift Valley Fever Infection in Eulemur fulvus (Brown Lemur) in Mayotte During an Interepidemic Period |
| Q40106750 | Absence of Rift Valley fever virus in domestic and wild ruminants from Spain. |
| Q43088458 | Absence of Rift Valley fever virus in wild small mammals, Madagascar |
| Q36414218 | Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein |
| Q40825493 | Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters |
| Q40606098 | Activity of Toscana and Rift Valley fever virus transcription complexes on heterologous templates. |
| Q40375427 | Acute renal failure associated with the Rift Valley fever: a single center study |
| Q35077969 | Advances in Rift Valley fever research: insights for disease prevention |
| Q38915999 | Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine |
| Q27305179 | Aedes mosquito saliva modulates Rift Valley fever virus pathogenicity |
| Q28486013 | Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development |
| Q37547173 | Aerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets |
| Q33927167 | Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection |
| Q104266582 | Alteration in the Culex pipiens transcriptome reveals diverse mechanisms of the mosquito immune system implicated upon Rift Valley fever phlebovirus exposure |
| Q42778332 | Alterations in the host transcriptome in vitro following Rift Valley fever virus infection |
| Q34034088 | An Assessment of the Regional and National Socio-Economic Impacts of the 2007 Rift Valley Fever Outbreak in Kenya |
| Q40398800 | An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus |
| Q30419750 | An assembly model of rift valley Fever virus |
| Q27486136 | An epidemic of Rift Valley fever in Egypt. 1. Diagnosis of Rift Valley fever in man |
| Q27486135 | An epidemic of Rift Valley fever in Egypt. 2. Isolation of the virus from animals |
| Q36180717 | An epidemiological model of Rift Valley fever with spatial dynamics |
| Q39240182 | An epizootic of Rift Valley fever in Egypt in 1977 |
| Q38853052 | An epizootic of Rift Valley fever in Egypt in 1997. |
| Q40043424 | An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep |
| Q40735286 | An immunocytochemical study of the distribution of Rift Valley fever virus in the mosquito Culex pipiens |
| Q40883692 | An inactivated rift valley fever vaccine |
| Q40508544 | An inhibition enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in humans, domestic and wild ruminants |
| Q39213428 | An investigation into an outbreak of Rift Valley fever on a cattle farm in Bela-Bela, South Africa, in 2008. |
| Q34034053 | An investigation of a major outbreak of Rift Valley fever in Kenya: 2006-2007 |
| Q40863697 | An ominous zoonosis: Rift Valley fever |
| Q37320063 | An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98. |
| Q46495184 | An outbreak of Rift Valley fever in the Sudan--1976. |
| Q34113798 | An unexpected recurrent transmission of Rift Valley fever virus in cattle in a temperate and mountainous area of Madagascar |
| Q38192773 | Analysis of surveillance systems in place in European Mediterranean countries for West Nile virus (WNV) and Rift Valley fever (RVF). |
| Q40656673 | Analysis of the 3' terminal sequence recognized by the Rift Valley fever virus transcription complex in its ambisense S segment |
| Q40777060 | Analytical study of a Rift Valley fever epidemic |
| Q37956499 | Animal models of Rift Valley fever virus infection |
| Q37535750 | Anomalous High Rainfall and Soil Saturation as Combined Risk Indicator of Rift Valley Fever Outbreaks, South Africa, 2008-2011 |
| Q47547438 | Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound. |
| Q34031858 | Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice |
| Q43088207 | Antibodies against Rift Valley fever virus in cattle, Mozambique |
| Q39304861 | Antibodies to Rift Valley Fever Virus in Swedish U.N. Soldiers in Egypt and the Sinai |
| Q45792281 | Antibodies to Rift Valley fever virus in the human population of Sudan |
| Q39215251 | Antibodies to hemorrhagic fever viruses in domestic livestock in Niger: Rift Valley fever and Crimean-Congo hemorrhagic fever. |
| Q40299380 | Antigen-capture ELISA for the detection of Rift Valley fever virus nucleoprotein using new monoclonal antibodies |
| Q40743074 | Antigenic analysis of Rift valley fever virus isolates: monoclonal antibodies distinguish between wild-type and neurotropic virus strains |
| Q40777781 | Antigenic and biological properties of Rift Valley fever virus isolated during the 1987 Mauritanian epidemic |
| Q40447812 | Antigenic and genetic relationships among Rift Valley fever virus and other selected members of the genus Phlebovirus (Bunyaviridae). |
| Q37633698 | Antiviral autophagy restrictsRift Valley fever virus infection and is conserved from flies to mammals |
| Q40109994 | Application of Droplet Digital PCR to Validate Rift Valley Fever Vaccines |
| Q35225634 | Application of knowledge-driven spatial modelling approaches and uncertainty management to a study of Rift Valley fever in Africa |
| Q33510919 | Application of polar-orbiting, meteorological satellite data to detect flooding of Rift Valley Fever virus vector mosquito habitats in Kenya |
| Q39618670 | Application of reverse transcriptase-polymerase chain reaction for detection of Rift Valley Fever viral antigen from mosquito. |
| Q38965916 | Applying the One Health principles: a trans-sectoral coordination framework for preventing and responding to Rift Valley fever outbreaks |
| Q40598958 | Arbovirus surveillance from 1990 to 1995 in the Barkedji area (Ferlo) of Senegal, a possible natural focus of Rift Valley fever virus |
| Q40382951 | Arbovirus surveillance of mosquitoes collected at sites of active Rift Valley fever virus transmission: Kenya, 2006-2007. |
| Q39611468 | Aspects of bioecology of two Rift Valley Fever Virus vectors in Senegal (West Africa): Aedes vexans and Culex poicilipes (Diptera: Culicidae). |
| Q40779650 | Assessment of an rDNA probe filter hybridization assay for the detection of Rift Valley fever virus RNA in human serum samples from the Mauritanian epidemic |
| Q40339826 | Assessment of the risk of introduction to Tunisia of the Rift Valley fever virus by the mosquito Culex pipiens |
| Q38808444 | Association of Rift Valley fever virus infection with miscarriage in Sudanese women: a cross-sectional study |
| Q38892638 | Association of ecological factors with Rift Valley fever occurrence and mapping of risk zones in Kenya |
| Q35165344 | Association of symptoms and severity of rift valley fever with genetic polymorphisms in human innate immune pathways |
| Q54217244 | Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates. |
| Q43167996 | Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain |
| Q37509225 | Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR. |
| Q40775631 | Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins |
| Q40292297 | Bead-based suspension array for simultaneous detection of antibodies against the Rift Valley fever virus nucleocapsid and Gn glycoprotein |
| Q40573616 | Bidirectional infection and release of Rift Valley fever virus in polarized epithelial cells |
| Q30152032 | Biochemical and biophysical characterization of cell-free synthesized Rift Valley fever virus nucleoprotein capsids enables in vitro screening to identify novel antivirals |
| Q40859660 | Biochemical characterization of Rift Valley fever virus |
| Q39426015 | Biological and antigenic relationship between Rift Valley fever virus strains isolated in Egypt and Madagascar |
| Q40953172 | Biological characteristics of plaque variants of Rift Valley fever virus |
| Q46207678 | Biological parameters of patients infected by the Rift Valley fever virus in Rosso (Mauritania) |
| Q36143143 | Biologically Informed Individual-Based Network Model for Rift Valley Fever in the US and Evaluation of Mitigation Strategies |
| Q34784520 | Biology of mosquitoes that are potential vectors of Rift Valley Fever virus in different biotopes of the central highlands of Madagascar |
| Q34226228 | Blood meal analysis and virus detection in blood-fed mosquitoes collected during the 2006-2007 Rift Valley fever outbreak in Kenya |
| Q37998608 | Breaking the chain: Rift Valley fever virus control via livestock vaccination |
| Q21092271 | Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever |
| Q40410471 | CVI and the Dutch Veterinary Faculty develop vaccines against Rift Valley fever |
| Q38440583 | Can environmental and socioeconomic factors explain the recent emergence of Rift Valley fever in Yemen, 2000-2001? |
| Q40423879 | Case report: Rift Valley Fever with vertical transmission in a pregnant Sudanese woman |
| Q40752880 | Changes in Rift Valley fever neutralizing antibody prevalence among small domestic ruminants following the 1987 outbreak in the Senegal River basin |
| Q37087027 | Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs |
| Q40787176 | Characterization of Attenuated Strains of Rift Valley Fever Virus |
| Q38328619 | Characterization of RNA aptamers directed against the nucleocapsid protein of Rift Valley fever virus. |
| Q28486276 | Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus |
| Q40448667 | Characterization of Rift Valley fever virus transcriptional terminations. |
| Q40757347 | Characterization of baculovirus-expressed Rift Valley fever virus glycoproteins synthesized in insect cells |
| Q40679919 | Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. |
| Q39686341 | Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein |
| Q38960700 | Characterization of wild-type and alternate transcription termination signals in the Rift Valley fever virus genome |
| Q40154881 | Characterizing the effect of Bortezomib on Rift Valley Fever Virus multiplication |
| Q27305612 | Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse |
| Q36548980 | Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever |
| Q36159670 | Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus. |
| Q38655917 | Climate Influence on Emerging Risk Areas for Rift Valley Fever Epidemics in Tanzania |
| Q40635980 | Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya |
| Q28749452 | Climate impacts on environmental risks evaluated from space: a conceptual approach to the case of Rift Valley Fever in Senegal |
| Q38456912 | Climate-disease connections: Rift Valley Fever in Kenya. |
| Q40878550 | Clinical studies on Rift Valley fever, Part I: Acute febrile and hemorrhagic-like diseases |
| Q40878545 | Clinical studies on Rift Valley fever. Part 2: Ophthalmologic and central nervous system complications |
| Q40463319 | Clinical, virological and serological response of the West African dwarf sheep to experimental infection with different strains of Rift Valley fever virus |
| Q40878528 | Clinico-pathological picture in five human cases died with Rift Valley fever |
| Q40217783 | Clone 13-infected Aedes aegypti salivary components inhibit Rift Valley fever virus pathogenicity |
| Q40461500 | Cloning and expression of Rift Valley fever virus nucleocapsid (N) protein and evaluation of a N-protein based indirect ELISA for the detection of specific IgG and IgM antibodies in domestic ruminants. |
| Q41929965 | Colorimetric Detection of Unamplified Rift Valley Fever Virus Genetic Material Using Unmodified Gold Nanoparticles. |
| Q54116240 | Combination Kinase Inhibitor Treatment Suppresses Rift Valley Fever Virus Replication. |
| Q34396130 | Combining hydrology and mosquito population models to identify the drivers of Rift Valley fever emergence in semi-arid regions of West Africa |
| Q28484936 | Common host-derived chemicals increase catches of disease-transmitting mosquitoes and can improve early warning systems for Rift Valley fever virus |
| Q39779815 | Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins |
| Q40199478 | Comparative efficacy of two next-generation Rift Valley fever vaccines |
| Q27481669 | Comparative pathogenicity and antigenic cross-reactivity of Rift Valley fever and other African phleboviruses in sheep |
| Q40348202 | Comparison of Enzyme-Linked Immunosorbent Assay–Based Techniques for the Detection of Antibody to Rift Valley Fever Virus in Thermochemically Inactivated Sheep Sera |
| Q35797105 | Comparison of Rift Valley fever virus replication in North American livestock and wildlife cell lines |
| Q40267008 | Comparison of a recombinant nucleocapsid IgG indirect ELISA with an IgG sandwich ELISA for the detection of antibodies to Rift Valley fever virus in small ruminants |
| Q40777161 | Comparison of in vitro and in vivo systems for propagation of Rift Valley fever virus from clinical specimens |
| Q40242939 | Comparison of sampling techniques for Rift Valley Fever virus potential vectors, Aedes aegypti and Culex pipiens complex, in Ngorongoro District in northern Tanzania |
| Q27481664 | Comparison of techniques for demonstrating antibodies to Rift Valley fever virus |
| Q39538225 | Comparison of the Potential for Different Genetic Forms in the Culex pipiens Complex in North America to Transmit Rift Valley Fever Virus |
| Q40734116 | Comparison of the pathogenicity for pregnant sheep of Rift Valley fever virus and a live attenuated vaccine |
| Q55262858 | Competence of mosquitoes native to the United Kingdom to support replication and transmission of Rift Valley fever virus. |
| Q38469369 | Competitive ELISA for the detection of antibodies to Rift Valley fever virus in goats and cattle |
| Q27478367 | Complete Genome Analysis of 33 Ecologically and Biologically Diverse Rift Valley Fever Virus Strains Reveals Widespread Virus Movement and Low Genetic Diversity due to Recent Common Ancestry |
| Q38854980 | Complete Genome Sequence of Rift Valley Fever Virus Strain Lunyo |
| Q37244410 | Complete Genome Sequence of Two Rift Valley Fever Virus Strains Isolated from Outbreaks in Saudi Arabia (2000) and Kenya (2006 to 2007). |
| Q40816483 | Complete nucleotide sequence of the M RNA segment of Rift Valley fever virus |
| Q40816475 | Complete sequences of the glycoproteins and M RNA of Punta Toro phlebovirus compared to those of Rift Valley fever virus |
| Q40507615 | Completion of the genome sequence of Rift Valley fever phlebovirus indicates that the L RNA is negative sense and codes for a putative transcriptase-replicase [corrected] |
| Q93556823 | Completion of the genome sequence of Rift Valley fever phlebovirus indicates that the L RNA is negative sense or ambisense and codes for a putative transcriptase-replicase |
| Q34729687 | Comprehensive phylogenetic reconstructions of Rift Valley fever virus: the 2010 northern Mauritania outbreak in the Camelus dromedarius species |
| Q38297831 | Computational prediction and biochemical characterization of novel RNA aptamers to Rift Valley fever virus nucleocapsid protein |
| Q40713941 | Concentration of Rift Valley Fever and Chikungunya Viruses by Precipitation |
| Q41000495 | Conditions necessary for interference of the neutropic virus with the pantropic virus of Rift Valley fever |
| Q42335792 | Correction: Integrated Analysis of Environment, Cattle and Human Serological Data: Risks and Mechanisms of Transmission of Rift Valley Fever in Madagascar |
| Q42327890 | Correction: Modelling Vaccination Strategies against Rift Valley Fever in Livestock in Kenya |
| Q54967688 | Correction: Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection. |
| Q49164360 | Correction: Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA. |
| Q42695109 | Correction: ecological niche modeling and land cover risk areas for rift valley fever vector, Culex tritaeniorhynchus giles in Jazan, Saudi Arabia |
| Q27330115 | Correlative Gene Expression to Protective Seroconversion in Rift Valley Fever Vaccinates |
| Q39597318 | Corrigendum to "Development of a Rift Valley fever real-time RT-PCR assay that can detect all three genome segments" [J. Virol. Methods 193 (2) (2014) 426-431]. |
| Q40630335 | Could bats act as reservoir hosts for Rift Valley fever virus? |
| Q33705717 | Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs |
| Q35438525 | Coupling Vector-host Dynamics with Weather Geography and Mitigation Measures to Model Rift Valley Fever in Africa. |
| Q34262159 | Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging |
| Q35531617 | Creation of a nonspreading Rift Valley fever virus |
| Q38748778 | Creation of a recombinant Rift Valley fever virus with a two-segmented genome |
| Q53903193 | Crimean-Congo haemorrhagic fever and Rift Valley fever in south-eastern Mauritania. |
| Q35140474 | Cross-sectional survey of Rift Valley fever virus exposure in Bodhei village located in a transitional coastal forest habitat in Lamu county, Kenya |
| Q24628170 | Crystal structure of glycoprotein C from Rift Valley fever virus |
| Q54942167 | Culex flavivirus infection in a Culex pipiens mosquito colony and its effects on vector competence for Rift Valley fever phlebovirus. |
| Q40817975 | Culex pipiens (Diptera: Culicidae) morbidity and mortality associated with Rift Valley fever virus infection |
| Q34281104 | Culex pipiens, an experimental efficient vector of West Nile and Rift Valley fever viruses in the Maghreb region. |
| Q36286082 | Curcumin inhibits Rift Valley fever virus replication in human cells. |
| Q41929716 | Current Status of Rift Valley Fever Vaccine Development |
| Q38503226 | Current status of Rift Valley fever. What lessons to deduce from the epidemics of 1977 and 1987? |
| Q36254960 | Cytokine response in mouse bone marrow derived macrophages after infection with pathogenic and non-pathogenic Rift Valley fever virus |
| Q45808086 | Cytological Changes in the Liver in Rift Valley Fever, with Special Reference to the Nuclear Inclusions |
| Q30000773 | Data-driven modeling to assess receptivity for Rift Valley Fever virus |
| Q47146973 | Datasets for mapping pastoralist movement patterns and risk zones of Rift Valley fever occurrence |
| Q38916438 | Decision making environment on Rift Valley fever in Ferlo (Senegal). |
| Q34034036 | Decision-Support Tool for Prevention and Control of Rift Valley Fever Epizootics in the Greater Horn of Africa |
| Q40707725 | Decrease of natural immunity against Rift Valley fever in domestic ruminants of the Senegal River basin after the epizootic outbreak of 1987 |
| Q35097798 | Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes |
| Q40766157 | Demonstration of Nuclear Immunofluorescence in Rift Valley Fever Infected Cells |
| Q40261786 | Description and analysis of the cattle trade network in the Madagascar highlands: potential role in the diffusion of Rift Valley fever virus |
| Q39194731 | Descriptive and spatial epidemiology of Rift valley fever outbreak in Yemen 2000-2001. |
| Q40767155 | Descriptive epidemiology of Rift Valley fever in small ruminants in Southern Mauritania after the 1988 rainy season |
| Q41032454 | Destruction of tumour cells by Rift Valley fever virus |
| Q40279271 | Detection and identification of Rift Valley fever virus in mosquito vectors by quantitative real-time PCR. |
| Q40311093 | Detection of Puumala and Rift Valley Fever virus by quantitative RT-PCR and virus viability tests in samples of blood dried and stored on filter paper |
| Q40936109 | Detection of Rift Valley Fever Virus by the Fluorescent Antibody Technique in Organs of Experimentally Infected Animals |
| Q40798660 | Detection of Rift Valley fever viral activity in Kenya by satellite remote sensing imagery |
| Q27489372 | Detection of Rift Valley fever virus antigen by enzyme-linked immunosorbent assay |
| Q40655928 | Detection of Rift Valley fever virus in mosquitoes by RT-PCR. |
| Q27488895 | Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay |
| Q34101068 | Detection of rift valley Fever virus interepidemic activity in some hotspot areas of kenya by sentinel animal surveillance, 2009-2012. |
| Q33806633 | Detection of the Northeastern African Rift Valley Fever Virus Lineage During the 2015 Outbreak in Mauritania |
| Q39823269 | Detection, isolation, and genetic characterization of Rift Valley fever virus from Anopheles (Anopheles) coustani, Anopheles (Anopheles) squamosus, and Culex (Culex) antennatus of the Haute Matsiatra region, Madagascar |
| Q46324455 | Developing a Research Agenda and a Comprehensive National Prevention and Response Plan for Rift Valley Fever in the United States. |
| Q27468693 | Development and Assessment of a Geographic Knowledge-Based Model for Mapping Suitable Areas for Rift Valley Fever Transmission in Eastern Africa |
| Q27487979 | Development and Evaluation of a Real-Time Reverse Transcription-Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Rift Valley Fever Virus in Clinical Specimens |
| Q38884966 | Development and characterization of Rift Valley fever virus-like particles |
| Q40237419 | Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors |
| Q40361059 | Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization |
| Q40302542 | Development and evaluation of one-step rRT-PCR and immunohistochemical methods for detection of Rift Valley fever virus in biosafety level 2 diagnostic laboratories |
| Q38925374 | Development and validation of serological assays for viral hemorrhagic fevers and determination of the prevalence of Rift Valley fever in Borno State, Nigeria |
| Q37321966 | Development of a RVFV ELISA that can distinguish infected from vaccinated animals |
| Q40241448 | Development of a Rift Valley fever real-time RT-PCR assay that can detect all three genome segments |
| Q40214312 | Development of a Rift Valley fever virus viremia challenge model in sheep and goats |
| Q40573754 | Development of a diagnostic one-tube RT-PCR for the detection of Rift Valley fever virus. |
| Q35826546 | Development of a novel nonhuman primate model for Rift Valley fever |
| Q35126733 | Development of a novel, single-cycle replicable rift valley Fever vaccine |
| Q40123495 | Development of a sheep challenge model for Rift Valley fever. |
| Q40231731 | Development of real-time RT-PCR for the detection of low concentrations of Rift Valley fever virus |
| Q40777411 | Diagnosis of a human case of Rift Valley fever by immunoperoxidase demonstration of antigen in fixed liver tissue |
| Q39597325 | Diagnostic approaches for Rift Valley fever |
| Q36559849 | Dicer-2- and Piwi-mediated RNA interference in Rift Valley fever virus-infected mosquito cells |
| Q39249793 | Differences in aerosolization of Rift Valley fever virus resulting from choice of inhalation exposure chamber: implications for animal challenge studies |
| Q41034446 | Different-sized infective particles of Rift Valley fever virus |
| Q40792679 | Differentiation of a human monocytic cell line associated with increased production of Rift Valley fever virus by infected cells |
| Q47562012 | Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse model |
| Q36284033 | Distribution and abundance of key vectors of Rift Valley fever and other arboviruses in two ecologically distinct counties in Kenya |
| Q35643842 | Distribution and diversity of the vectors of Rift Valley fever along the livestock movement routes in the northeastern and coastal regions of Kenya |
| Q40652216 | Distribution of Rift Valley fever among cattle in Zambia |
| Q40660109 | Distribution of viral antigen in tissues of new-born lambs infected with Rift Valley fever virus. |
| Q40481588 | Domestic transmission of Rift Valley Fever virus in Diawara (Senegal) in 1998. |
| Q38667970 | Drivers for Rift Valley fever emergence in Mayotte: A Bayesian modelling approach |
| Q37626187 | Drivers of Rift Valley fever epidemics in Madagascar. |
| Q35107614 | Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. |
| Q40727773 | Duration of immunoglobulin M antibodies against Rift Valley fever virus in cattle after natural infection |
| Q31104371 | Dynamic risk model for Rift Valley fever outbreaks in Kenya based on climate and disease outbreak data |
| Q39240193 | Ecological and epidemiological studies of Rift Valley fever in Egypt |
| Q26700137 | Ecological differentiation of members of the Culex pipiens complex, potential vectors of West Nile virus and Rift Valley fever virus in Algeria |
| Q47556353 | Ecological distribution and population dynamics of Rift Valley fever virus mosquito vectors (Diptera, Culicidae) in Senegal |
| Q34770212 | Ecological niche modeling and land cover risk areas for rift valley fever vector, culex tritaeniorhynchus giles in Jazan, Saudi Arabia. |
| Q31143311 | Ecological niche modelling of Rift Valley fever virus vectors in Baringo, Kenya |
| Q40199434 | Economic Assessment of Zoonotic Diseases: An Illustrative Study of Rift Valley Fever in the United States. |
| Q40954155 | Effect of Imput Multiplicity and Tissue Cell Concentration on Growth of Rift Valley Fever Virus |
| Q40767968 | Effect of Rift Valley fever virus on pregnant and non-pregnant local Barki ewes after artificial infection. |
| Q44140108 | Effect of environmental temperature on the susceptibility of Culex pipiens (Diptera: Culicidae) to Rift Valley fever virus |
| Q40777151 | Effect of environmental temperature on the vector competence of Aedes fowleri for Rift Valley fever virus |
| Q40709269 | Effect of environmental temperature on the vector competence of Aedes taeniorhynchus for Rift Valley fever and Venezuelan equine encephalitis viruses |
| Q40814412 | Effect of extrinsic incubation temperature on the ability of Aedes taeniorhynchus and Culex pipiens to transmit Rift Valley fever virus |
| Q40702197 | Effect of the developmental stage at infection on the ability of adult Anopheles stephensi to transmit Rift Valley fever virus. |
| Q40075417 | Effects of Irrigation and Rainfall on the Population Dynamics of Rift Valley Fever and Other Arbovirus Mosquito Vectors in the Epidemic-Prone Tana River County, Kenya |
| Q40203534 | Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs |
| Q40686078 | Efficacy of Coxiella burnetii and its chloroform-methanol residue (CMR) fraction against Rift Valley fever virus infection in mice |
| Q40743768 | Efficacy of a Rift Valley fever virus vaccine against an aerosol infection in rats |
| Q39198268 | Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep |
| Q40768918 | Efficacy of a sustained-release methoprene formulation on potential vectors of Rift Valley fever virus in field studies in Kenya. |
| Q50329180 | Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccination |
| Q40292321 | Efficacy of three candidate Rift Valley fever vaccines in sheep. |
| Q34704620 | Efficient cellular release of Rift Valley fever virus requires genomic RNA. |
| Q39893246 | Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses |
| Q40751002 | Egg hatching of Aedes mosquitoes during successive floodings in a Rift Valley fever endemic area in Kenya |
| Q40397884 | Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers |
| Q40734422 | Electron microscopic identification of Zinga virus as a strain of Rift Valley fever virus |
| Q40949456 | Electron microscopic studies on BHK 21 cells infected with rift valley fever virus |
| Q35272576 | Elevated antibodies against Rift Valley fever virus among humans with exposure to ruminants in Saudi Arabia |
| Q28085230 | Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus |
| Q40386303 | Endemic transmission of Rift Valley Fever in Senegal |
| Q51043228 | Enemies and turncoats: bovine tuberculosis exposes pathogenic potential of Rift Valley fever virus in a common host, African buffalo (Syncerus caffer). |
| Q36098640 | Enhanced detection of Rift Valley fever virus using molecular assays on whole blood samples |
| Q27478096 | Enhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever virus infection in mice |
| Q53689108 | Enhanced surveillance for Rift Valley Fever in livestock during El Niño rains and threat of RVF outbreak, Kenya, 2015-2016. |
| Q28361917 | Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice |
| Q31072923 | Environmental change and Rift Valley fever in eastern Africa: projecting beyond HEALTHY FUTURES. |
| Q40654394 | Enzootic activity of Rift Valley fever virus in Senegal |
| Q40819529 | Enzyme-linked immunosorbent assay for detection of Rift Valley fever virus antigen in mosquitoes |
| Q40795428 | Enzyme-linked immunosorbent assay for detection of antibodies to Rift Valley fever virus in ovine and bovine sera. |
| Q39162251 | Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness |
| Q40567114 | Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans |
| Q39093726 | Epidemic of Rift Valley fever (RVF) in Egypt: isolation of RVF virus from animals |
| Q40878509 | Epidemic of Rift Valley fever (RVF) in Egypt: virological diagnosis of RVF in man |
| Q33698865 | Epidemic of Rift Valley fever in the Islamic republic of Mauritania. Geographic and ecological data |
| Q49846543 | Epidemiologic Investigations into Outbreaks of Rift Valley Fever in Humans, South Africa, 2008-2011. |
| Q34034096 | Epidemiologic and Clinical Aspects of a Rift Valley Fever Outbreak in Humans in Tanzania, 2007 |
| Q35984787 | Epidemiologic and Environmental Risk Factors of Rift Valley Fever in Southern Africa from 2008 to 2011. |
| Q34034081 | Epidemiological Assessment of the Rift Valley Fever Outbreak in Kenya and Tanzania in 2006 and 2007 |
| Q22330892 | Epidemiological notes on some viruses isolated in Uganda; Yellow fever, Rift Valley fever, Bwamba fever, West Nile, Mengo, Semliki forest, Bunyamwera, Ntaya, Uganda S and Zika viruses |
| Q36035996 | Epidemiological processes involved in the emergence of vector-borne diseases: West Nile fever, Rift Valley fever, Japanese encephalitis and Crimean-Congo haemorrhagic fever |
| Q39202011 | Epidemiological studies of Rift Valley fever in certain governorates in Egypt |
| Q40200902 | Epidemiological study of Rift Valley fever virus in Kigoma, Tanzania |
| Q38987382 | Epidemiological study of outbreak of Rift Valley fever among military personnel |
| Q40754966 | Epidemiology of Rift Valley fever in west Africa. 1. Serological investigation of small ruminants in Niger |
| Q39119869 | Epidemiology of brucellosis, Q Fever and Rift Valley Fever at the human and livestock interface in northern Côte d'Ivoire |
| Q40795193 | Epizootic of Rift Valley fever in Zambia, 1985. |
| Q36300604 | Ethnic groups' knowledge, attitude and practices and Rift Valley fever exposure in Isiolo County of Kenya |
| Q40272959 | European ring trial to evaluate ELISAs for the diagnosis of infection with Rift Valley fever virus |
| Q30501476 | Evaluation of Factors Related to Growth of Rift Valley Fever Virus in Suspended Cell Cultures |
| Q54251506 | Evaluation of Fluorescence Microsphere Immunoassay for the Detection of Antibodies to Rift Valley Fever Nucleocapsid Protein and Glycoproteins. |
| Q40391443 | Evaluation of a commercial competitive ELISA for the detection of antibodies to Rift Valley fever virus in sera of domestic ruminants in France |
| Q40858817 | Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep |
| Q40805536 | Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials |
| Q40768043 | Evaluation of indicators of health in the area of Trarza during the epidemic of Rift Valley fever in 1987 |
| Q40206211 | Evaluation of lamb and calf responses to Rift Valley fever MP-12 vaccination |
| Q40198870 | Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigen. |
| Q40426903 | Evaluation of pathways for release of Rift Valley fever virus into domestic ruminant livestock, ruminant wildlife, and human populations in the continental United States |
| Q31156487 | Evaluation of positive Rift Valley fever virus formalin-fixed paraffin embedded samples as a source of sequence data for retrospective phylogenetic analysis. |
| Q35902010 | Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep. |
| Q40358602 | Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep |
| Q33981667 | Evidence for circulation of the rift valley fever virus among livestock in the union of Comoros |
| Q38827944 | Evidence for enzootic circulation of Rift Valley fever virus among livestock in Cameroon |
| Q35155772 | Evidence of Rift Valley fever seroprevalence in the Sahrawi semi-nomadic pastoralist system, Western Sahara |
| Q44057897 | Exotic disease in our area: Rift Valley fever |
| Q26315437 | Experimental Infection of Calves by Two Genetically-Distinct Strains of Rift Valley Fever Virus |
| Q40951908 | Experimental Infection of Cattle with Pantropic Rift Valley Fever Virus |
| Q40896935 | Experimental Rift Valley fever in West African Dwarf sheep |
| Q40789442 | Experimental Rift Valley fever in rhesus macaques |
| Q40521379 | Experimental detection of Rift Valley fever virus by reverse transcription-polymerase chain reaction assay in large samples of mosquitoes |
| Q40808330 | Experimental infection and protection of lambs with a minute plaque variant of Rift Valley fever virus. |
| Q40849902 | Experimental infection of the African buffalo with the virus of Rift Valley fever |
| Q33497390 | Experimental infection of three Nigerian breeds of sheep with the Zinga strain of the Rift Valley Fever virus |
| Q40348206 | Experimental infection of young adult European breed sheep with Rift Valley fever virus field isolates. |
| Q39240168 | Experimental transmission and field isolation studies implicating Culex pipiens as a vector of Rift Valley fever virus in Egypt. |
| Q47555207 | Experimental transmission of West Nile Virus and Rift Valley Fever Virus by Culex pipiens from Lebanon |
| Q34406901 | Exploratory space-time analyses of Rift Valley Fever in South Africa in 2008-2011 |
| Q38943726 | Exposure of sheep to mosquito bites: possible consequences for the transmission risk of Rift Valley Fever in Senegal |
| Q52719610 | Expression of a Recombinant Nucleocapsid Protein of Rift Valley Fever Virus in Vero Cells as an Immunofluorescence Antigen and Its Use for Serosurveillance in Traditional Cattle Herds in Zambia. |
| Q54267574 | Expression of cytokines following vaccination of goats with a recombinant capripoxvirus vaccine expressing Rift Valley fever virus proteins. |
| Q40108424 | Expression strategy of a phlebovirus: biogenesis of proteins from the Rift Valley fever virus M segment |
| Q33693568 | Facets of the Rift Valley fever outbreak in Northeastern Province, Kenya, 2006-2007. |
| Q40663046 | Facilitation of Rift Valley fever virus transmission by Plasmodium berghei sporozoites in Anopheles stephensi mosquitoes |
| Q40455257 | Factors associated with rift valley fever in south-west Saudi Arabia. |
| Q35170892 | Factors associated with severe human Rift Valley fever in Sangailu, Garissa County, Kenya |
| Q40871400 | Fatal Rift Valley fever of man in Rhodesia |
| Q38467931 | Fatal haemorrhagic rift valley fever: a case at Madagascar |
| Q36957867 | Fatal outcome of hepatitis A virus (HAV) infection in a traveler with incomplete HAV vaccination and evidence of Rift Valley Fever virus infection |
| Q37683496 | Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment |
| Q40296528 | Field evaluation of a wicking assay for the rapid detection of Rift Valley fever viral antigens in mosquitoes |
| Q90751763 | Field-captured Aedes vexans (Meigen, 1830) is a competent vector for Rift Valley fever phlebovirus in Europe |
| Q40777408 | Filter paper confetti in a serological Rift Valley fever survey |
| Q35840989 | First External Quality Assessment of Molecular and Serological Detection of Rift Valley Fever in the Western Mediterranean Region |
| Q40734565 | First fatal human case of Rift Valley fever in Madagascar |
| Q40604475 | First isolation of the Rift Valley fever virus from Culex poicilipes (Diptera: Culicidae) in nature |
| Q40956789 | First serologic verification of the incidence of Wesselsbronn's disease and Rift Valley Fever in sheep and wild ruminants in Chad and Cameroon |
| Q93180955 | First serological evidence of the Rift valley fever Phlebovirus in Tunisian camels |
| Q38885112 | First serological investigation of peste-des-petits-ruminants and Rift Valley fever in Tunisia |
| Q40911441 | Fluorescent and neutralizing antibody response to infection by Rift Valley fever virus |
| Q45839983 | Focus of Rift Valley fever virus transmission in southern Mauritania |
| Q40170227 | Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination |
| Q34429914 | Functional analysis of Rift Valley fever virus NSs encoding a partial truncation |
| Q40753243 | Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep |
| Q41011212 | Further notes on the interference of the inactive virus of Rift Valley fever with the active homologous virus |
| Q40779661 | General aspects of the 1987 Rift Valley fever epidemic in Mauritania |
| Q40232418 | Generation and application of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein NP and glycoproteins Gn and Gc. |
| Q40312818 | Generation and characterization of a recombinant Rift Valley fever virus expressing a V5 epitope-tagged RNA-dependent RNA polymerase. |
| Q40216012 | Generation and characterization of monoclonal antibodies against Rift Valley fever virus nucleoprotein. |
| Q40757944 | Generation and transmission of Rift Valley fever viral reassortants by the mosquito Culex pipiens |
| Q38778411 | Generation of a Single-Cycle Replicable Rift Valley Fever Vaccine |
| Q27489550 | Genetic Analysis of Viruses Associated with Emergence of Rift Valley Fever in Saudi Arabia and Yemen, 2000-01 |
| Q40327417 | Genetic evidence for Rift Valley fever outbreaks in Madagascar resulting from virus introductions from the East African mainland rather than enzootic maintenance |
| Q39601913 | Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs |
| Q27469727 | Genetic reassortment of Rift Valley fever virus in nature |
| Q44170263 | Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells |
| Q36414512 | Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strains |
| Q38891360 | Genetic variation among geographic isolates of Rift Valley fever virus |
| Q35979880 | Genome analysis of Rift Valley fever virus, Mayotte |
| Q39721010 | Geographically weighted discriminant analysis of environmental conditions associated with Rift Valley fever outbreaks in South Africa |
| Q40941135 | Growth of Rift Valley fever virus in human diploid (WI-38) cells |
| Q40923816 | Heat- and Acid-Labile Virus-Inhibiting Factor or Interferon Induced by Rift Valley Fever Virus in Mice |
| Q40440836 | Hemorrhagic Rift Valley fever |
| Q40775204 | Hemostatic derangement produced by Rift Valley fever virus in rhesus monkeys |
| Q40273179 | Heparan sulfate facilitates Rift Valley fever virus entry into the cell |
| Q21144476 | High content image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA viruses |
| Q34222724 | High seroprevalence of Rift Valley FEVER AND EVIDENCE FOR ENDEMIC circulation in Mbeya region, Tanzania, in a cross-sectional study |
| Q47722420 | High seroprevalence of Rift Valley fever phlebovirus in domestic ruminants and African Buffaloes in Mozambique shows need for intensified surveillance. |
| Q35893112 | High-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection |
| Q36314304 | Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus |
| Q33918307 | Host alternation is necessary to maintain the genome stability of rift valley fever virus |
| Q39015000 | Host feeding of mosquitoes (Diptera: Culicidae) associated with the recurrence of Rift Valley fever in Egypt |
| Q41084108 | Human infection with Rift Valley fever virus and immunity twelve years after single attack. |
| Q40882428 | Hydrops amnii in sheep associated with hydranencephaly and arthrogryposis with wesselsbron disease and rift valley fever viruses as aetiological agents |
| Q37036679 | IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus |
| Q40972593 | IMMUNIZATION AGAINST RIFT VALLEY FEVER VIRUS. STUDIES ON THE IMMUNOGENICITY OF LYOPHILIZED FORMALIN-INACTIVATED VACCINE |
| Q36462318 | Identification of Rift Valley fever virus nucleocapsid protein-RNA binding inhibitors using a high-throughput screening assay |
| Q40844168 | Identification of a major non-structural protein in the nuclei of Rift Valley fever virus-infected cells |
| Q40776401 | Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virus |
| Q40359899 | Identification of potential vectors of and detection of antibodies against Rift Valley fever virus in livestock during interepizootic periods |
| Q39197757 | Identification of suitable areas for the occurrence of Rift Valley fever outbreaks in Spain using a multiple criteria decision framework |
| Q38880677 | Identifying Areas Suitable for the Occurrence of Rift Valley Fever in North Africa: Implications for Surveillance |
| Q28703345 | Identifying landscape features associated with Rift Valley fever virus transmission, Ferlo region, Senegal, using very high spatial resolution satellite imagery |
| Q39193651 | IgG-sandwich and IgM-capture enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in domestic ruminants |
| Q40871807 | Immune response of steers, goats and sheep to inactivated Rift Valley Fever vaccine |
| Q40984281 | Immunization against Rift Valley fever. The development of vaccines from nonprimate cell cultures and chick embryos. |
| Q40792421 | Immunoelectron microscopy of Rift Valley fever viral morphogenesis in primary rat hepatocytes |
| Q40939699 | Immunofluorescent cell-counting assay of Rift Valley fever virus |
| Q34529382 | Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice |
| Q39778317 | Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study. |
| Q37254943 | Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves. |
| Q40632227 | Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. |
| Q40498246 | Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus |
| Q40463330 | Immunological reactions of Rift Valley fever virus strains from East and West Africa |
| Q40742126 | Impact of stressful conditions on the survival of Culex pipiens exposed to Rift Valley fever virus |
| Q38498822 | Impact of veterinary arboviruses. The case of Rift Valley Fever |
| Q40080864 | Import of Rift Valley fever to China: a potential new threat? |
| Q40425544 | In vitro activity of Russian ribavirin on the models of Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, and Tahyna and Dhori viruses |
| Q39197938 | Inactivation of infectious virus and serological detection of virus antigen in Rift Valley fever virus-exposed mosquitoes fixed with paraformaldehyde |
| Q40847485 | Inbred rat strains mimic the disparate human response to Rift Valley fever virus infection |
| Q40823678 | Increased Mosquito Feeding on Rift Valley Fever Virus-Infected Lambs * |
| Q40556173 | Indirect enzyme-linked immunosorbent assay for the detection of antibody against Rift Valley fever virus in domestic and wild ruminant sera. |
| Q35801885 | Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication |
| Q40545597 | Induction of severe disease in hamsters by two sandfly fever group viruses, Punta toro and Gabek Forest (Phlebovirus, Bunyaviridae), similar to that caused by Rift Valley fever virus. |
| Q40919649 | Induction of virus-inhibiting factor or interferon in mice by strains with different virulence of Rift Valley fever virus |
| Q34260234 | Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection |
| Q40748547 | Infection of inbred rat strains with Rift Valley fever virus: development of a congenic resistant strain and observations on age-dependence of resistance |
| Q40146936 | Infectious, immunogenic, and protective characteristics of the Rift Valley fever virus depending on the passage level and storage conditions |
| Q33429285 | Inflammatory Biomarkers Associated with Lethal Rift Valley Fever Encephalitis in the Lewis Rat Model |
| Q40775294 | Ingestion of immune bloodmeals and infection of Aedes fowleri, Aedes mcintoshi, and Culex pipiens with Rift Valley fever virus. |
| Q28367982 | Inhibition of RNA viruses in vitro and in Rift Valley fever-infected mice by didemnins A and B |
| Q34597759 | Inhibition of Rift Valley fever virus replication and perturbation of nucleocapsid-RNA interactions by suramin |
| Q41025328 | Inhibition of multiplication of Rift Valley fever virus by homologous virus irradiated by ultraviolet rays |
| Q41019682 | Inhibition of multiplication of virus in Rift Valley fever by homologous virus irradiated with ultraviolet rays. II |
| Q40044869 | Innate Immune Basis for Rift Valley Fever Susceptibility in Mouse Models. |
| Q34251382 | Innate immune response to Rift Valley fever virus in goats |
| Q26315222 | Integrated Analysis of Environment, Cattle and Human Serological Data: Risks and Mechanisms of Transmission of Rift Valley Fever in Madagascar |
| Q38677880 | Inter-epidemic Rift Valley fever virus seroconversions in an irrigation scheme in Bura, south-east Kenya |
| Q35002597 | Inter-epidemic abundance and distribution of potential mosquito vectors for Rift Valley fever virus in Ngorongoro district, Tanzania |
| Q35130104 | Inter-epidemic acquisition of Rift Valley fever virus in humans in Tanzania. |
| Q37420463 | Inter-epidemic and between-season persistence of rift valley fever: vertical transmission or cryptic cycling? |
| Q34952316 | Inter-epidemic transmission of Rift Valley fever in livestock in the Kilombero River Valley, Tanzania: a cross-sectional survey |
| Q40717906 | Interacting factors that influence long-term storage of live Pasteurella tularensis vaccine and Rift Valley fever virus |
| Q37009607 | Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya |
| Q41015617 | Interference between active and ultraviolet-irradiated Rift Valley fever virus |
| Q40595885 | Interferon-induced rat Mx proteins confer resistance to Rift Valley fever virus and other arthropod-borne viruses. |
| Q21562243 | International external quality assessment of molecular detection of Rift Valley fever virus |
| Q38376184 | Interplay between the Virus and Host in Rift Valley Fever Pathogenesis |
| Q53682526 | Interspecific network centrality, host range and early-life development are associated with wildlife hosts of Rift Valley fever virus. |
| Q45372924 | Interventions Against West Nile Virus, Rift Valley Fever Virus, and Crimean-Congo Hemorrhagic Fever Virus: Where Are We? |
| Q40368584 | Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus |
| Q40257752 | Is the United States really at risk for introduction of Rift Valley fever virus? |
| Q27489553 | Isolation and Genetic Characterization of Rift Valley fever virus from Aedes vexans arabiensis, Kingdom of Saudi Arabia |
| Q45329064 | Isolation and phylogenetic study of Rift Valley fever virus from the first imported case to China |
| Q43937147 | Isolation of Crimean-Congo haemorrhagic fever and Rift Valley fever viruses in Upper Volta |
| Q40751582 | Isolation of Rift Valley Fever Virus from Mosquitoes (Diptera: Culicidae) Collected During an Outbreak in Domestic Animals in Kenya |
| Q40816030 | Isolation of Rift Valley fever virus from cattle abortions in Tanzania |
| Q40775515 | Isolation of Rift Valley fever virus from human peripheral blood mononuclear cells: Mauritanian epidemic |
| Q40779658 | Isolation of the Rift Valley fever virus by inoculation into Aedes pseudoscutellaris cells: comparison with other diagnostic methods |
| Q39538231 | Isolation of west nile and sindbis viruses from mosquitoes collected in the Nile Valley of Egypt during an outbreak of Rift Valley fever |
| Q40417897 | Kinetics of Rift Valley Fever Virus in experimentally infected mice using quantitative real-time RT-PCR. |
| Q35840960 | Knowledge, Attitudes and Practices (KAP) on Rift Valley Fever among Pastoralist Communities of Ijara District, North Eastern Kenya |
| Q28608583 | Knowledge, attitudes and practices on Rift Valley fever among agro pastoral communities in Kongwa and Kilombero districts, Tanzania |
| Q40878532 | Laboratory findings in some cases of Rift Valley fever: histopathological haematological, and biochemical |
| Q40400233 | Laboratory safe detection of nucleocapsid protein of Rift Valley fever virus in human and animal specimens by a sandwich ELISA. |
| Q40521383 | Laboratory transmission of Rift Valley fever virus by Phlebotomus duboscqi, Phlebotomus papatasi, Phlebotomus sergenti, and Sergentomyia schwetzi (Diptera: Psychodidae). |
| Q36353686 | Landscape Genetics of Aedes mcintoshi (Diptera: Culicidae), an Important Vector of Rift Valley Fever Virus in Northeastern Kenya |
| Q40277454 | Large-scale chromatin immunoprecipitation with promoter sequence microarray analysis of the interaction of the NSs protein of Rift Valley fever virus with regulatory DNA regions of the host genome |
| Q35892951 | Lay perceptions of risk factors for Rift Valley fever in a pastoral community in northeastern Kenya |
| Q40908064 | Long term existence of Rift Valley Fever virus in immune mice |
| Q40324199 | Lymphoplasmacytic endotheliitis and anterior uveitis in sheep infected experimentally with rift valley fever virus |
| Q40289937 | MBT/Pas mouse: a relevant model for the evaluation of Rift Valley fever vaccines. |
| Q35792819 | MP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamsters |
| Q41052286 | Macular changes in rift valley fever. |
| Q46975916 | Manifestations of severe Rift Valley fever in Sudan |
| Q40538339 | Mapping Rift Valley Fever vectors and prevalence using rainfall variations |
| Q40132046 | Mapping a Major Gene for Resistance to Rift Valley Fever Virus in Laboratory Rats |
| Q40642621 | Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation |
| Q40404470 | Mapping of zones potentially occupied by Aedes vexans and Culex poicilipes mosquitoes, the main vectors of Rift Valley fever in Senegal |
| Q40848509 | Marburg, Ebola and Rift Valley Fever virus antibodies in East African primates |
| Q40821129 | Mechanical transmission of Rift Valley fever virus by hematophagous Diptera |
| Q34490520 | Mechanism of tripartite RNA genome packaging in Rift Valley fever virus |
| Q92214926 | Mechanisms of inter-epidemic maintenance of Rift Valley fever phlebovirus |
| Q28554535 | Mechanistic Insight into the Host Transcription Inhibition Function of Rift Valley Fever Virus NSs and Its Importance in Virulence |
| Q40808123 | Messenger RNA of the M segment RNA of Rift Valley fever virus |
| Q33831160 | Modeling the distribution of the West Nile and Rift Valley Fever vector Culex pipiens in arid and semi-arid regions of the Middle East and North Africa |
| Q30814248 | Modeling the impact of climate change on the dynamics of Rift Valley Fever |
| Q36876822 | Modeling the spatial spread of Rift Valley fever in Egypt |
| Q36223549 | Modelling Vaccination Strategies against Rift Valley Fever in Livestock in Kenya. |
| Q36626548 | Modelling hotspots of the two dominant Rift Valley fever vectors (Aedes vexans and Culex poicilipes) in Barkédji, Sénégal |
| Q30421040 | Modelling the effects of seasonality and socioeconomic impact on the transmission of rift valley Fever virus |
| Q34660072 | Modelling vertical transmission in vector-borne diseases with applications to Rift Valley fever |
| Q36489477 | Modifying the NSs gene to improve live-attenuated vaccine for Rift Valley fever. |
| Q40216006 | Molecular and serological studies on the Rift Valley fever outbreak in Mauritania in 2010. |
| Q36652695 | Molecular biology and genetic diversity of Rift Valley fever virus |
| Q33886954 | Molecular biology of rift valley Fever virus |
| Q40220077 | Molecular detection of Rift Valley fever virus in serum samples from selected areas of Tanzania |
| Q44140079 | Molecular epidemiology and emergence of Rift Valley fever |
| Q35849036 | Molecular epidemiology of Rift Valley fever virus |
| Q40154443 | Monitoring of the antiviral potential of bee venom and wax extracts against Adeno-7 (DNA) and Rift Valley fever virus (RNA) viruses models. |
| Q45806308 | Monoclonal antibodies to identify Zinga virus as Rift Valley Fever virus |
| Q44144338 | More deaths from Rift Valley fever in Saudi Arabia and Yemen |
| Q38991875 | Morphology and development of Rift Valley fever virus in Vero cell cultures |
| Q24701810 | Mosquito host choices on livestock amplifiers of Rift Valley fever virus in Kenya |
| Q40506193 | Mosquito vectors of the 1998-1999 outbreak of Rift Valley Fever and other arboviruses (Bagaza, Sanar, Wesselsbron and West Nile) in Mauritania and Senegal |
| Q39623442 | Mosquitoes and the Environment in Nile Delta Villages with Previous Rift Valley Fever Activity |
| Q40083734 | Mouse model for the Rift Valley fever virus MP12 strain infection. |
| Q40317212 | Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine |
| Q40789943 | Mucosal priming alters pathogenesis of Rift Valley fever |
| Q33583806 | Multi-faceted proteomic characterization of host protein complement of Rift Valley fever virus virions and identification of specific heat shock proteins, including HSP90, as important viral host factors |
| Q40048134 | Multiple virus lineages sharing recent common ancestry were associated with a Large Rift Valley fever outbreak among livestock in Kenya during 2006-2007. |
| Q38845048 | Multiplex Detection of IgG and IgM to Rift Valley Fever Virus Nucleoprotein, Nonstructural Proteins, and Glycoprotein in Ovine and Bovine. |
| Q41003192 | Multiplication of Rift Valley fever virus in human liver cell culture with special reference to production complement fixing antigen. |
| Q41024803 | Multiplication of neurotropic Rift Valley fever virus in Ehrlich ascites tumor cells. |
| Q41010911 | Multiplication of the neurotropic strain of Rift Valley fever virus in the spleen and liver of mice |
| Q40814834 | Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development |
| Q54257544 | Mutation of adjacent cysteine residues in the NSs protein of Rift Valley fever virus results in loss of virulence in mice. |
| Q37049951 | Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression. |
| Q47265320 | Mutational analysis of Rift Valley fever phlebovirus nucleocapsid protein indicates novel conserved, functional amino acids. |
| Q36947068 | N-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN. |
| Q35024013 | NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. |
| Q36315241 | NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis |
| Q38774860 | NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR |
| Q39960501 | NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription |
| Q39195523 | NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase |
| Q39547955 | NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. |
| Q38601911 | NSs protein of severe fever with thrombocytopenia syndrome virus suppresses interferon production through different mechanism than Rift Valley fever virus |
| Q51336493 | Neutralizing antibodies against flaviviruses, Babanki virus, and Rift Valley fever virus in Ugandan bats. |
| Q40988106 | Neutralizing antibody response of sheep to pantropic and neutrotropic rift valley fever virus |
| Q24273388 | New vectors of Rift Valley fever in West Africa |
| Q22940978 | Ngari virus in goats during Rift Valley fever outbreak, Mauritania, 2010 |
| Q40130716 | Nonspreading Rift Valley Fever Virus Infection of Human Dendritic Cells Results in Downregulation of CD83 and Full Maturation of Bystander Cells. |
| Q39778891 | Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. |
| Q40730767 | Nonvascular delivery of Rift Valley fever virus by infected mosquitoes |
| Q38852321 | Notes from the Field: Rift Valley Fever Response - Kabale District, Uganda, March 2016. |
| Q41061623 | Notes on Rift Valley fever. |
| Q39676525 | Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles |
| Q37252699 | Nuclear relocalization of polyadenylate binding protein during rift valley fever virus infection involves expression of the NSs gene |
| Q35690127 | Observations on rift valley fever virus and vaccines in Egypt |
| Q27483018 | Observations on the epidemiology of Rift Valley fever in Kenya |
| Q40936288 | Observations on the growth and development of bluetongue, nairobi sheep disease and Rift Valley Fever viruses by fluorescent antibody technique and titration in a tissue culture system |
| Q30207853 | Occurrence of rift valley fever in cattle in Ijara district, Kenya |
| Q40878537 | Ocular complications of Rift Valley fever |
| Q40515567 | Ocular complications of Rift Valley fever outbreak in Saudi Arabia |
| Q40864346 | Ocular disease resulting from infection with Rift Valley fever virus |
| Q40878637 | Ocular manifestations of Rift Valley Fever |
| Q38200401 | One Health approach to Rift Valley fever vaccine development |
| Q47144027 | Opinion of the Scientific Panel on Animal Health and Welfare (AHAW) on a request from the Commission related to “The Risk of a Rift Valley Fever Incursion and its Persistence within the Community” |
| Q40439262 | Optical fiber immunosensor for the detection of IgG antibody to Rift Valley fever virus in humans |
| Q39725145 | Outbreak of Rift Valley fever affecting veterinarians and farmers in South Africa, 2008. |
| Q39192548 | Outbreak of Rift Valley fever--Saudi Arabia, August-October, 2000. |
| Q39192623 | Outbreak of Rift Valley fever--Yemen, August-October 2000. |
| Q43167772 | Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach. |
| Q27483643 | PHYSICAL AND SEROLOGICAL INVESTIGATION OF RIFT VALLEY FEVER ANTIGENS |
| Q40979702 | PIGS AND RIFT VALLEY FEVER. |
| Q40968999 | PROTECTION OF MICE AND LAMBS AGAINST PANTROPIC RIFT VALLEY FEVER VIRUS, USING IMMUNE SERUM |
| Q40982522 | PURIFICATION AND ELECTRON MICROSCOPY OF PANTROPIC RIFT VALLEY FEVER VIRUS. |
| Q40049043 | Packaging of Rift Valley fever virus pseudoviruses and establishment of a neutralization assay method |
| Q40744759 | Palmitoylation of cysteine 69 from the COOH-terminal of band 3 protein in the human erythrocyte membrane. Acylation occurs in the middle of the consensus sequence of F--I-IICLAVL found in band 3 protein and G2 protein of Rift Valley fever virus |
| Q41065298 | Pantotropic virus. IV. Rift Valley fever virus |
| Q40785341 | Panveld oviposition sites of floodwater Aedes mosquitoes and attempts to detect transovarial transmission of Rift Valley fever virus in South Africa |
| Q38957617 | Paramyxovirus-based production of Rift Valley fever virus replicon particles |
| Q40616443 | Pathogen-specific resistance to Rift Valley fever virus infection is induced in mosquito cells by expression of the recombinant nucleoprotein but not NSs non-structural protein sequences |
| Q40768376 | Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response |
| Q40798305 | Pathogenesis of Rift Valley fever virus (RVFV) in inbred rats |
| Q39407293 | Pathogenesis of Rift Valley fever virus in mosquitoes--tracheal conduits & the basal lamina as an extra-cellular barrier. |
| Q38663795 | Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted |
| Q39442255 | Pathogenic effects of Rift Valley fever virus NSs gene are alleviated in cultured cells by expressed antiviral short hairpin RNAs. |
| Q40795447 | Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes |
| Q40557158 | Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys |
| Q27481366 | Pathogenicity of different strains of Rift Valley fever virus in Swiss albino mice |
| Q34034044 | Pathologic studies on suspect animal and human cases of Rift Valley fever from an outbreak in Eastern Africa, 2006-2007. |
| Q37274070 | Pathological studies on postvaccinal reactions of Rift Valley fever in goats |
| Q36505970 | Patterns of Rift Valley fever activity in Zambia |
| Q40169222 | Perceived risk factors and risk pathways of Rift Valley fever in cattle in Ijara district, Kenya |
| Q44169686 | Peripheral blood biomarkers of disease outcome in a monkey model of Rift Valley Fever encephalitis |
| Q40660523 | Persistent infection of mammalian cells by Rift Valley fever virus |
| Q48097495 | Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection |
| Q40191372 | Phylogeographic Reconstructions of a Rift Valley Fever Virus Strain Reveals Transboundary Animal Movements from Eastern Continental Africa to the Union of the Comoros |
| Q28469517 | Phylogeography of Rift Valley Fever Virus in Africa and the Arabian Peninsula |
| Q34249345 | Phylogeography of Rift Valley Fever virus in Africa reveals multiple introductions in Senegal and Mauritania |
| Q28742390 | Planning for Rift Valley fever virus: use of geographical information systems to estimate the human health threat of white-tailed deer (Odocoileus virginianus)-related transmission |
| Q26315432 | Plant resting site preferences and parity rates among the vectors of Rift Valley Fever in northeastern Kenya |
| Q41027391 | Plaque formation with Rift Valley fever virus |
| Q34633660 | Population genetics of two key mosquito vectors of Rift Valley Fever virus reveals new insights into the changing disease outbreak patterns in Kenya |
| Q40752746 | Possible Rift Valley fever outbreak in man and cattle in Madagascar |
| Q40865056 | Possible vectors of Rift Valley fever in Kenya |
| Q36879979 | Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge |
| Q34000103 | Postepidemic analysis of Rift Valley fever virus transmission in northeastern kenya: a village cohort study |
| Q36852321 | Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle |
| Q40114294 | Potential application of silver nanoparticles to control the infectivity of Rift Valley fever virus in vitro and in vivo |
| Q36053652 | Potential effects of Rift Valley fever in the United States |
| Q40296536 | Potential for Canadian mosquitoes to transmit Rift Valley fever virus |
| Q40346522 | Potential for North American Mosquitoes (Diptera: Culicidae) to Transmit Rift Valley Fever Virus |
| Q40398345 | Potential for North American mosquitoes to transmit Rift Valley fever virus |
| Q40140711 | Potential for Psorophora columbiae and Psorophora ciliata Mosquitoes (Diptera: Culicidae) to Transmit Rift Valley Fever Virus |
| Q37166123 | Potential for autoimmune pathogenesis of Rift Valley Fever virus retinitis |
| Q40751106 | Potential for mosquito transmission of attenuated strains of Rift Valley fever virus |
| Q40229732 | Potential for mosquitoes (Diptera: Culicidae) from Florida to transmit Rift Valley fever virus |
| Q40238831 | Potential for populations of Aedes j. japonicus to transmit Rift Valley fever virus in the USA. |
| Q40335291 | Potential for stable flies and house flies (Diptera: Muscidae) to transmit Rift Valley fever virus |
| Q40414505 | Potential vectors of Rift Valley fever virus in the Mediterranean region |
| Q28354111 | Predicting Rift Valley Fever Inter-epidemic Activities and Outbreak Patterns: Insights from a Stochastic Host-Vector Model |
| Q37231456 | Predicting distribution of Aedes aegypti and Culex pipiens complex, potential vectors of Rift Valley fever virus in relation to disease epidemics in East Africa |
| Q34165833 | Predicting the mosquito species and vertebrate species involved in the theoretical transmission of Rift Valley fever virus in the United States |
| Q37061637 | Prediction of a Rift Valley fever outbreak |
| Q34034069 | Prediction, Assessment of the Rift Valley Fever Activity in East and Southern Africa 2006–2008 and Possible Vector Control Strategies |
| Q35903303 | Predictive Factors and Risk Mapping for Rift Valley Fever Epidemics in Kenya |
| Q27482801 | Preliminary survey of domestic animals of the Sudan for precipitating antibodies to Rift Valley fever virus |
| Q40462117 | Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA. |
| Q39182576 | Preparation and use of a stable, inactivated Rift Valley fever antigen |
| Q36568775 | Presence of Viral RNA and Proteins in Exosomes from Cellular Clones Resistant to Rift Valley Fever Virus Infection |
| Q40625798 | Present status of an arbovirus infection: yellow fever, its natural history of hemorrhagic fever, Rift Valley fever |
| Q54221968 | Prevalence and risk factors of Rift Valley fever in humans and animals from Kabale district in Southwestern Uganda, 2016. |
| Q35979894 | Prevalence of Rift Valley Fever among ruminants, Mayotte |
| Q40787004 | Prevalence of Rift Valley Fever in Lusaka and Mazabuka, Zambia |
| Q40012303 | Prevalence of Rift Valley fever immunoglobulin G antibody in various occupational groups before the 2007 outbreak in Tanzania |
| Q39024903 | Prevalence of Rift Valley fever in domestic ruminants in the central and northern regions of Burkina Faso. |
| Q40331250 | Prevalence of Rift Valley fever infection in ruminants in Madagascar after the 2008 outbreak |
| Q27486535 | Prevalence of anti-Rift-Valley-fever IgM antibody in abattoir workers in the Nile delta during the 1993 outbreak in Egypt |
| Q28752180 | Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife |
| Q40782788 | Prevalence of antibodies against Rift Valley fever virus in sheep and goats in Senegal |
| Q38953827 | Prevalence of antibody to Rift Valley fever virus in the Nile river delta of Egypt, 13 years after a major outbreak |
| Q40775763 | Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha. |
| Q39953693 | Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep. |
| Q40501140 | Production of monoclonal antibodies against Rift Valley fever virus Application for rapid diagnosis tests (virus detection and ELISA) in human sera |
| Q60925687 | Productive Propagation of Rift Valley Fever Phlebovirus Vaccine Strain MP-12 in Rousettus aegyptiacus Fruit Bats |
| Q41028566 | Propagation of Rift Valley fever virus in ascites hepatoma cells of the rat: production of a new variant of the virus |
| Q40815181 | Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice |
| Q40806370 | Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator |
| Q40202028 | Protection against Rift Valley fever virus infection in mice upon administration of interferon-inducing RNA transcripts from the FMDV genome |
| Q40365121 | Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-/-) mice induced by different DNA vaccination regimens. |
| Q40321756 | Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus |
| Q34431934 | Protection of Sheep against Rift Valley Fever Virus and Sheep Poxvirus with a Recombinant Capripoxvirus Vaccine |
| Q40473787 | Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever. |
| Q35912398 | Protein Kinase R Degradation Is Essential for Rift Valley Fever Virus Infection and Is Regulated by SKP1-CUL1-F-box (SCF)FBXW11-NSs E3 Ligase |
| Q36668959 | Protein Phosphatase-1 regulates Rift Valley fever virus replication |
| Q40827849 | Protein synthesis in Rift Valley fever virus-infected cells |
| Q37510694 | Public Health Benefits from Livestock Rift Valley Fever Control: A Simulation of Two Epidemics in Kenya |
| Q38964465 | Quantifying the potential pathways and locations of Rift Valley fever virus entry into the United States. |
| Q39467349 | Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds |
| Q41096732 | RIFT VALLEY FEVER : A REPORT OF THREE CASES OF LABORATORY INFECTION AND THE EXPERIMENTAL TRANSMISSION OF THE DISEASE TO FERRETS. |
| Q41097128 | RIFT VALLEY FEVER IN MAN : REPORT OF A FATAL LABORATORY INFECTION COMPLICATED BY THROMBOPHLEBITIS. |
| Q33634293 | RNA Interference Restricts Rift Valley Fever Virus in Multiple Insect Systems |
| Q36759999 | RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge |
| Q27487321 | RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses |
| Q38963344 | Rainfall and epizootic Rift Valley fever. |
| Q40504138 | Rainfall patterns and population dynamics of Aedes (Aedimorphus) vexans arabiensis, Patton 1905 (Diptera: Culicidae), a potential vector of Rift Valley Fever virus in Senegal. |
| Q28652554 | Randomized controlled field trial to assess the immunogenicity and safety of rift valley fever clone 13 vaccine in livestock |
| Q35541050 | Ranking of prophylactic efficacy of poly(ICLC) against Rift Valley fever virus infection in mice by incremental relative risk of death |
| Q38820203 | Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis |
| Q27491320 | Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA |
| Q27471311 | Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. |
| Q40779655 | Rapid detection of Rift Valley fever antigen in the serum of infected lambs |
| Q40779646 | Rapid diagnosis of Rift Valley fever: a comparison of methods for the direct detection of viral antigen in human sera |
| Q40878503 | Rapid diagnosis of arboviral and similar infections of man: Rift Valley fever in Egypt, 1977 |
| Q40241939 | Re-emergence of Rift Valley fever virus in Barkedji (Senegal, West Africa) in 2002-2003: identification of new vectors and epidemiological implications |
| Q40221530 | Reactive oxygen species activate NFκB (p65) and p53 and induce apoptosis in RVFV infected liver cells |
| Q27487305 | Real-Time Reverse-Transcription Loop-Mediated Isothermal Amplification for Rapid Detection of Rift Valley Fever Virus |
| Q35769810 | Reassortment and distinct evolutionary dynamics of Rift Valley Fever virus genomic segments |
| Q45324172 | Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection. |
| Q30881378 | Recent data on Rift Valley Fever epidemiology in Senegal |
| Q34292066 | Recent outbreaks of rift valley Fever in East Africa and the middle East |
| Q40489874 | Recognizing Rift Valley Fever. |
| Q40744262 | Recombinant Human Interferon-γ Modulates Rift Valley Fever Virus Infection in the Rhesus Monkey |
| Q35202797 | Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice |
| Q40438632 | Recombinant nucleocapsid-based ELISA for detection of IgG antibody to Rift Valley fever virus in African buffalo |
| Q34280142 | Recombinase polymerase amplification assay for rapid detection of Rift Valley fever virus |
| Q28359552 | Reconstruction of Rift Valley fever transmission dynamics in Madagascar: estimation of force of infection from seroprevalence surveys using Bayesian modelling |
| Q40737079 | Recoverability of Rift Valley fever and sandfly fever Sicilian viruses from infected Phlebotomus papatasi (Diptera: Psychodidae) trapped in various oils |
| Q38880763 | Recurrence of Rift Valley fever in Egypt |
| Q40781570 | Reduced Rift Valley fever virus infection rates in mosquitoes associated with pledget feedings. |
| Q40848409 | Reduced pathogenicity associated with a small plaque variant of the Egyptian strain of Rift Valley fever virus (ZH501). |
| Q40806403 | Reduced recovery of Rift Valley fever virus associated with assay of mosquito (Diptera: Culicidae) larval pools |
| Q40793941 | Reduced survival of adult Culex pipiens infected with Rift Valley fever virus |
| Q37513461 | Reemergence of Rift Valley fever, Mauritania, 2010. |
| Q40930978 | Relationship Between Plaque Assay and the Mouse Assay for Titrating Rift Valley Fever Virus |
| Q35716641 | Relationship of climate, geography, and geology to the incidence of Rift Valley fever in Kenya during the 2006-2007 outbreak |
| Q92993831 | Relative Distribution, Diversity, and Bloodmeal Sources of Mosquitoes and Known Vectors of Rift Valley Fever Phlebovirus in Three Differing Ecosystems in Bura, Tana River County, Kenya |
| Q38091739 | Relevance of Rift Valley fever to public health in the European Union |
| Q39356757 | Remote sensing and geographic information systems to predict the density of ruminants, hosts of Rift Valley fever virus in the Sahel. |
| Q40830060 | Replication and dissemination of Rift Valley fever virus in Culex pipiens. |
| Q40348212 | Replication of Clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, in Aedes and Culex mosquitoes |
| Q40828705 | Replication of Rift Valley fever virus in the sand fly Lutzomyia longipalpis. |
| Q39119864 | Reprint of "Epidemiology of brucellosis, Q Fever and Rift Valley Fever at the human and livestock interface in northern Côte d'Ivoire". |
| Q35718193 | Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection |
| Q40311587 | Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene |
| Q40613342 | Resistance to Rift Valley fever virus in Rattus norvegicus: genetic variability within certain 'inbred' strains |
| Q38892505 | Respiratory infectivity of a recently isolated Egyptian strain of Rift Valley fever virus |
| Q40602250 | Response of laboratory staff to vaccination with an inactivated Rift Valley fever vaccine--TSI-GSD 200. |
| Q38642139 | Response to Rift Valley Fever in Tanzania: Challenges and Opportunities. |
| Q38614407 | Restriction of rift valley Fever virus virulence in mosquito cells |
| Q40857512 | Retinal abnormalities caused by Rift Valley fever virus |
| Q33570326 | Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines |
| Q33745109 | Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift valley fever virus in human small airway epithelial cells |
| Q40836472 | Reversed passive hemagglutination and inhibition with Rift Valley fever and Crimean-Congo hemorrhagic fever viruses |
| Q34034103 | Rift Valley Fever Outbreak in Livestock in Kenya, 2006–2007 |
| Q37535789 | Rift Valley Fever Outbreak in Livestock, Mozambique, 2014. |
| Q27487840 | Rift Valley Fever Outbreak, Mauritania, 1998: Seroepidemiologic, Virologic, Entomologic, and Zoologic Investigations |
| Q39034249 | Rift Valley Fever Seroprevalence in Coastal Kenya |
| Q42553036 | Rift Valley Fever Vaccine Development, Progress and Constraints |
| Q35975309 | Rift Valley Fever Vaccine Virus Clone 13 Is Able to Cross the Ovine Placental Barrier Associated with Foetal Infections, Malformations, and Stillbirths |
| Q27928016 | Rift Valley Fever Virus Circulating among Ruminants, Mosquitoes and Humans in the Central African Republic |
| Q34034059 | Rift Valley Fever Virus Epidemic in Kenya, 2006/2007: The Entomologic Investigations |
| Q40983070 | Rift Valley Fever Virus Hepatitis: Light and Electron Microscopic Studies in the Mouse |
| Q34475358 | Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments. |
| Q36418114 | Rift Valley Fever Virus among Wild Ruminants, Etosha National Park, Namibia, 2011. |
| Q38991879 | Rift Valley Fever Virus: Some Ultrastructural Observations on Material from the Outbreak in Egypt 1977 |
| Q33881845 | Rift Valley Fever among febrile patients at New Halfa hospital, eastern Sudan |
| Q39022333 | Rift Valley Fever and its epidemiology in Egypt: a review |
| Q40860806 | Rift Valley Fever and its relation to the 4th plague. |
| Q47547037 | Rift Valley Fever in Egypt and other African countries: historical review, recent outbreaks and possibility of disease occurrence in Egypt |
| Q40287697 | Rift Valley Fever in Southwestern Saudi Arabia: a sero-epidemiological study seven years after the outbreak of 2000-2001. |
| Q37584088 | Rift Valley Fever outbreaks in Mauritania and related environmental conditions |
| Q42616474 | Rift Valley Fever potential, Arabian Peninsula |
| Q40259783 | Rift Valley Fever virus in mice. I. General features of the infection |
| Q40259887 | Rift Valley Fever virus in mice. II. Adsorption and multiplication of virus |
| Q40260149 | Rift Valley Fever virus in mice. III. Further quantitative features of the infective process |
| Q40260073 | Rift Valley Fever virus in mice. IV. Incomplete virus; its production and properties |
| Q38855401 | Rift Valley Fever virus infections in Egypt: pathological and virological findings in man |
| Q27488329 | Rift Valley Fever, Mayotte, 2007–2008 |
| Q40866894 | Rift Valley Fever, a Veterinary and Medical Problem (author's transl) |
| Q46933218 | Rift Valley Fever--East Africa, 1997-1998. |
| Q52665091 | Rift Valley Fever. |
| Q40870960 | Rift Valley Fever. A survey for antibody to the virus in bird species commonly found in situations considered to be enzootic |
| Q51784408 | Rift Valley Fever: A survey of knowledge, attitudes, and practice of slaughterhouse workers and community members in Kabale District, Uganda. |
| Q38776944 | Rift Valley Fever: An Emerging Mosquito-Borne Disease |
| Q41922817 | Rift Valley Fever: Does Wildlife Play a Role? |
| Q34034031 | Rift Valley Fever: Scientific Pathways Toward Public Health Prevention and Response |
| Q44018416 | Rift Valley Fever: the role of the vervet monkey as a reservoir or maintenance host for this virus |
| Q38471294 | Rift Valley Fever: veterinary aspects and impact for human health |
| Q40490691 | Rift Valley fever |
| Q40334988 | Rift Valley fever |
| Q36514844 | Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates. |
| Q40882124 | Rift Valley fever affecting humans in South Africa: a clinicopathological study |
| Q40248036 | Rift Valley fever among children and adolescents in southwestern Saudi Arabia |
| Q40779643 | Rift Valley fever among domestic animals in the recent West African outbreak |
| Q41001843 | Rift Valley fever and Rift Valley rodents |
| Q36574005 | Rift Valley fever and a new paradigm of research and development for zoonotic disease control |
| Q40736941 | Rift Valley fever antibody in human sera collected after an outbreak in domestic animals in Kenya |
| Q40691608 | Rift Valley fever antibody prevalence in domestic ungulates in Cameroon and several west African countries (1989-1992) following the 1987 Mauritanian outbreak |
| Q53965975 | Rift Valley fever as a possible cause of human abortions. |
| Q41013295 | Rift Valley fever as a veterinary and medical problem |
| Q46498699 | Rift Valley fever caused the fifth plague of Egypt and that of 1977. |
| Q34908264 | Rift Valley fever during rainy seasons, Madagascar, 2008 and 2009. |
| Q30698447 | Rift Valley fever dynamics in Senegal: a project for pro-active adaptation and improvement of livestock raising management |
| Q40871392 | Rift Valley fever encephalitis. A description of a case |
| Q33357041 | Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics |
| Q37872751 | Rift Valley fever epidemiology, surveillance, and control: what have models contributed? |
| Q40684732 | Rift Valley fever epizootic in small ruminants in southern Mauritania (October 1993): risk of extensive outbreaks |
| Q40727647 | Rift Valley fever epizootic in the central highlands of Madagascar |
| Q40536038 | Rift Valley fever hepatitis complicated by disseminated intravascular coagulation and hepatorenal syndrome |
| Q40531759 | Rift Valley fever in Chad |
| Q40822562 | Rift Valley fever in Chisamba, Zambia. |
| Q38916015 | Rift Valley fever in Egypt 1986. Surveillance of sheep flocks grazing in the northeast Nile Delta |
| Q46827266 | Rift Valley fever in Egypt, 1978 |
| Q24273380 | Rift Valley fever in Kedougou, southeastern Senegal, 2012 |
| Q40358435 | Rift Valley fever in Kenya: history of epizootics and identification of vulnerable districts |
| Q40818858 | Rift Valley fever in Kenya: the presence of antibody to the virus in camels (Camelus dromedarius). |
| Q40741336 | Rift Valley fever in Madagascar in 1991. Sero-epidemiological studies in cattle |
| Q37343711 | Rift Valley fever in Namibia, 2010. |
| Q40663881 | Rift Valley fever in Nigeria: infections in domestic animals. |
| Q40663886 | Rift Valley fever in Nigeria: infections in humans. |
| Q41008332 | Rift Valley fever in Rhodesia; report of a case in a laboratory worker |
| Q41052747 | Rift Valley fever in South Africa: 2. The occurrence of human cases in the Orange Free State, the north-western Cape province, the western and southern Transvaal. A Epidemiological and clinical findings. |
| Q41008327 | Rift Valley fever in Southern Rhodesia. |
| Q40462020 | Rift Valley fever in West Africa: the role of space in endemicity. |
| Q40801336 | Rift Valley fever in Western Africa |
| Q41014905 | Rift Valley fever in a wild field rat (Arvicanthis abyssinicus): a possible natural host |
| Q39560537 | Rift Valley fever in a zone potentially occupied by Aedes vexans in Senegal: dynamics and risk mapping |
| Q40982586 | Rift Valley fever in camels |
| Q40858033 | Rift Valley fever in humans in South Africa |
| Q40106234 | Rift Valley fever in kidney transplant recipient returning from Mali with viral RNA detected in semen up to four months from symptom onset, France, autumn 2015. |
| Q40700580 | Rift Valley fever in rural northern Senegal: human risk factors and potential vectors. |
| Q28728879 | Rift Valley fever in small ruminants, Senegal, 2003 |
| Q40766341 | Rift Valley fever in the Sudan |
| Q40777156 | Rift Valley fever infection of rhesus monkeys: implications for rapid diagnosis of human disease |
| Q33651877 | Rift Valley fever ocular manifestations: observations during the 1977 epidemic in Egypt |
| Q40743528 | Rift Valley fever on the east coast of Madagascar |
| Q38986027 | Rift Valley fever outbreak in Egypt. October--December 1977 |
| Q33884060 | Rift Valley fever outbreak with East-Central African virus lineage in Mauritania, 2003. |
| Q37513478 | Rift Valley fever outbreak, southern Mauritania, 2012. |
| Q40458723 | Rift Valley fever outbreak--Kenya, November 2006-January 2007. |
| Q40038707 | Rift Valley fever phlebovirus NSs protein core domain structure suggests molecular basis for nuclear filaments |
| Q40852589 | Rift Valley fever retinitis. |
| Q34805801 | Rift Valley fever risk map model and seroprevalence in selected wild ungulates and camels from Kenya |
| Q38869593 | Rift Valley fever surveillance in mobile sheep flocks in the Nile Delta |
| Q30244855 | Rift Valley fever trasmission dynamics described by compartmental models. |
| Q40866726 | Rift Valley fever vaccine--antibody and immune response in cattle to a live and an inactivated vaccine |
| Q39251803 | Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate. |
| Q51784251 | Rift Valley fever vaccines: current and future needs. |
| Q26315215 | Rift Valley fever vector diversity and impact of meteorological and environmental factors on Culex pipiens dynamics in the Okavango Delta, Botswana |
| Q34971963 | Rift Valley fever virus |
| Q40513778 | Rift Valley fever virus |
| Q27482900 | Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya |
| Q40700712 | Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases |
| Q40785843 | Rift Valley fever virus M segment: cell-free transcription and translation of virus-complementary RNA. |
| Q40783794 | Rift Valley fever virus M segment: cellular localization of M segment-encoded proteins |
| Q40774379 | Rift Valley fever virus M segment: phlebovirus expression strategy and protein glycosylation |
| Q40129877 | Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression |
| Q37006803 | Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice |
| Q40137585 | Rift Valley fever virus NSS gene expression correlates with a defect in nuclear mRNA export |
| Q36501737 | Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR. |
| Q40499504 | Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment |
| Q33406230 | Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation |
| Q40735889 | Rift Valley fever virus activity in East Africa in 1989 |
| Q40044386 | Rift Valley fever virus and European mosquitoes: vector competence of Culex pipiens and Stegomyia albopicta (= Aedes albopictus). |
| Q36827204 | Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses |
| Q40581805 | Rift Valley fever virus ecology and the epidemiology of disease emergence |
| Q39877530 | Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector |
| Q45332431 | Rift Valley fever virus imported into China from Angola |
| Q36154746 | Rift Valley fever virus in mice. V. The properties of a haemagglutinin present in infective serum |
| Q41011867 | Rift Valley fever virus in mice. VI. Histological changes in the liver in relation to virus multiplication |
| Q40679927 | Rift Valley fever virus in the cardia of Culex pipiens: an immunocytochemical and ultrastructural study. |
| Q31149260 | Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells. |
| Q42537845 | Rift Valley fever virus infection among French troops in Chad |
| Q34707871 | Rift Valley fever virus infection in African buffalo (Syncerus caffer) herds in rural South Africa: evidence of interepidemic transmission |
| Q28543047 | Rift Valley fever virus infection in golden Syrian hamsters |
| Q37634027 | Rift Valley fever virus infection induces activation of the NLRP3 inflammasome |
| Q39200964 | Rift Valley fever virus infections in Egyptian cattle and their prevention |
| Q40308414 | Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection. |
| Q40453546 | Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. |
| Q40289172 | Rift Valley fever virus noncoding regions of L, M and S segments regulate RNA synthesis |
| Q33644365 | Rift Valley fever virus seroprevalence in human rural populations of Gabon |
| Q36397378 | Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis |
| Q40237478 | Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep. |
| Q36797004 | Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins. |
| Q39754768 | Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge |
| Q39015055 | Rift Valley fever virus transmission by different Egyptian mosquito species |
| Q34221766 | Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep |
| Q40817416 | Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humans |
| Q40847013 | Rift Valley fever virus vaccine trial: study of side-effects in humans |
| Q33960690 | Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention |
| Q40727210 | Rift Valley fever virus-induced encephalomyelitis and hepatitis in calves |
| Q26795706 | Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe |
| Q30151926 | Rift Valley fever virus: Unanswered questions |
| Q39368427 | Rift Valley fever virus: a seroepidemiologic study of small terrestrial vertebrates in South Africa |
| Q40360325 | Rift Valley fever virus: an unrecognized emerging threat? |
| Q38471692 | Rift Valley fever virus: evolution in progress |
| Q38757716 | Rift Valley fever virus: strategies for maintenance, survival and vertical transmission in mosquitoes |
| Q39445205 | Rift Valley fever, Egypt 1977: disease spread by windborne insect vectors? |
| Q36573983 | Rift Valley fever, Sudan, 2007 and 2010 |
| Q38935927 | Rift Valley fever--Egypt, 1993. |
| Q37733822 | Rift Valley fever--a threat for Europe? |
| Q50934159 | Rift Valley fever. |
| Q52655181 | Rift Valley fever. |
| Q53928614 | Rift Valley fever. |
| Q40915248 | Rift Valley fever. 1. Vector studies in the field |
| Q40913050 | Rift Valley fever. 2. Attempts to transmit virus with seven species of mosquito. |
| Q40911612 | Rift Valley fever. 3. Viraemia in cattle and sheep. 4. The susceptibility of mice and hamsters in relation to transmission of virus by mosquitoes |
| Q36472655 | Rift Valley fever: a sero-epidemiological survey among pregnant women in Mozambique |
| Q40877751 | Rift Valley fever: an historical perspective |
| Q35077306 | Rift Valley fever: an uninvited zoonosis in the Arabian peninsula |
| Q36305805 | Rift Valley fever: present status and risk to the Western Hemisphere |
| Q38495160 | Rift Valley fever: sporadic infection of French military personnel outside currently recognized epidemic zones |
| Q40084099 | Rift Valley fever: still an emerging infection after 3500 years |
| Q40337142 | Rift Valley fever: the Nigerian story |
| Q41071528 | Rift Valley fever; accidental infections among laboratory workers. |
| Q28760734 | Rift Valley fever; isolation of the virus from wild mosquitoes |
| Q36131361 | Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine |
| Q36131367 | Rift Valley fever; transmission of the virus by mosquitoes. |
| Q40225260 | Rift valley Fever in Kruger national park: do buffalo play a role in the inter-epidemic circulation of virus? |
| Q28539632 | Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model |
| Q36218889 | Rift valley Fever: lessons to be learned |
| Q34255610 | Rift valley fever |
| Q40267628 | Rift valley fever |
| Q40830358 | Rift valley fever and Zinga virus: a pathogenic arbovirus in man and animal new for Madagascar |
| Q40886386 | Rift valley fever and rickettsial retinitis including fluorescein angiography (author's transl) |
| Q40075804 | Rift valley fever epidemic in Niger near border with Mali |
| Q41052370 | Rift valley fever in South Africa. 2. The occurrence of human cases in the Orange Free State, the North-Western Cape Province, the Western and Southern Transvaal. B. Field and laboratory investigation |
| Q41028066 | Rift valley fever in South Africa; a study of the 1953 outbreak in the Orange Free State, with special reference to the vectors and possible reservoir hosts |
| Q40861053 | Rift valley fever in abattoir workers |
| Q35009824 | Rift valley fever in humans and animals in Mayotte, an endemic situation? |
| Q41052278 | Rift valley fever in man, complicated by retinal changes and loss of vision. |
| Q43203696 | Rift valley fever in ruminants, Republic of Comoros, 2009. |
| Q40650746 | Rift valley fever retinopathy: Observations in a new outbreak. |
| Q40632284 | Rift valley fever surveillance in the lower Senegal river basin: update 10 years after the epidemic |
| Q37393780 | Rift valley fever vaccines |
| Q40377637 | Rift valley fever virus L protein forms a biologically active oligomer |
| Q41005187 | Rift valley fever virus in the one-day-old chick embryo |
| Q40864281 | Rift valley fever virus infection in man in Nigeria |
| Q33760778 | Rift valley fever virus infection of human cells and insect hosts is promoted by protein kinase C epsilon |
| Q36484009 | Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals |
| Q33755025 | Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system |
| Q40859030 | Rift valley fever. A threat for Middle Europe? |
| Q27486840 | Rift valley fever: propagation and methods of control |
| Q34174444 | Rift valley fever: recent insights into pathogenesis and prevention |
| Q41053117 | Rift valley fever; I. The occurrence of human cases in Johannesburg |
| Q41677275 | Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain |
| Q39196376 | Risk assessment of the introduction of Rift Valley fever from the Horn of Africa to Yemen via legal trade of small ruminants |
| Q35214579 | Risk factors associated with Rift Valley fever epidemics in South Africa in 2008-11. |
| Q38253960 | Risk factors associated with human Rift Valley fever infection: systematic review and meta-analysis |
| Q34034024 | Risk factors for severe Rift Valley fever infection in Kenya, 2007. |
| Q36516678 | Risk of a rift valley fever epidemic at the haj in Mecca, Saudi Arabia. |
| Q39001432 | Rodenticide-induced signs simulating Rift Valley fever in sheep and goats in Egypt |
| Q30227254 | Role of Culex and Anopheles mosquito species as potential vectors of rift valley fever virus in Sudan outbreak, 2007. |
| Q39046970 | Role of the cytosolic tails of Rift Valley fever virus envelope glycoproteins in viral morphogenesis. |
| Q39406139 | Roles of the coding and noncoding regions of rift valley Fever virus RNA genome segments in viral RNA packaging |
| Q40597208 | SEROPREVALENCE OF RIFT VALLEY FEVER AMONG SLAUGHTERHOUSE PERSONNEL IN MAKKAH DURING HAJJ 1419h (1999). |
| Q40982509 | STUDIES ON RIFT VALLEY FEVER IN LABORATORY ANIMALS. |
| Q28066283 | Safety and Efficacy Profile of Commercial Veterinary Vaccines against Rift Valley Fever: A Review Study |
| Q40322035 | Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves |
| Q40645625 | Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle |
| Q36085506 | Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels |
| Q40144467 | Safety and immunogenicity of Onderstepoort Biological Products' Rift Valley fever Clone 13 vaccine in sheep and goats under field conditions in Senegal. |
| Q40124756 | Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans. |
| Q36501630 | Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep. |
| Q40645618 | Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids |
| Q47153200 | Scientific Opinion on Rift Valley fever |
| Q39480622 | Screening for Rift Valley fever infection in northern Somalia: a GIS based survey method to overcome the lack of sampling frame |
| Q40900988 | Selection of avirulent variants of Rift Valley fever virus. |
| Q40220083 | Sensitivity and specificity of real-time reverse transcription polymerase chain reaction, histopathology, and immunohistochemical labeling for the detection of Rift Valley fever virus in naturally infected cattle and sheep |
| Q40752380 | Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian sandfly fever, and Uukuniemi viruses |
| Q34764573 | Sequential Rift Valley fever outbreaks in eastern Africa caused by multiple lineages of the virus |
| Q40844069 | Sequential development of the liver lesions in new-born lambs infected with Rift Valley fever virus. I. Macroscopic and microscopic pathology |
| Q40844064 | Sequential development of the liver lesions in new-born lambs infected with Rift Valley fever virus. II. Ultrastructural findings |
| Q36359356 | Seroepidemiological Study of Interepidemic Rift Valley Fever Virus Infection Among Persons with Intense Ruminant Exposure in Madagascar and Kenya |
| Q40077385 | Seroepidemiological Survey of Rift Valley Fever Virus in Ruminants in Garissa, Kenya |
| Q40243781 | Seroepidemiological study of west nile virus and rift valley Fever virus in some of Mammalian species (herbivores) in northern Turkey |
| Q40163527 | Seroepidemiological survey on Rift Valley fever among small ruminants and their close human contacts in Makkah, Saudi Arabia, in 2011. |
| Q40774199 | Seroepidemiological survey on Rift Valley fever in Zambia |
| Q36371106 | Serologic evidence of exposure to Rift Valley fever virus detected in Tunisia |
| Q40877724 | Serologic response of man to inactivated Rift Valley fever vaccine |
| Q40062059 | Serological Evidence for the Circulation of Rift Valley Fever Virus in Domestic Small Ruminants in Southern Gabon |
| Q28606628 | Serological Evidence of Rift Valley Fever Virus Circulation in Domestic Cattle and African Buffalo in Northern Botswana (2010-2011) |
| Q40075001 | Serological and genomic evidence of Rift Valley fever virus during inter-epidemic periods in Mauritania |
| Q40727767 | Serological evidence in sheep suggesting phlebovirus circulation in a Rift Valley fever enzootic area in Burkina Faso |
| Q34613594 | Serological evidence of Rift Valley fever virus circulation in sheep and goats in Zambézia Province, Mozambique |
| Q45806269 | Serological evidence of endemic Zinga virus and Rift Valley Fever virus in Central African Republic |
| Q53695031 | Serological evidence of rift valley fever Phlebovirus and Crimean-Congo hemorrhagic fever orthonairovirus infections among pygmies in the east region of Cameroon. |
| Q27469092 | Serological evidence of rift valley fever virus among acute febrile patients in Southern Mozambique during and after the 2013 heavy rainfall and flooding: implication for the management of febrile illness |
| Q45806715 | Serological relation between Rift Valley fever virus and viruses of phlebotomus fever serogroup |
| Q40153798 | Serological surveillance studies confirm the Rift Valley fever virus free status in South Korea |
| Q40740934 | Serological survey of Rift Valley fever in sheep on the Ivory Coast |
| Q40942226 | Serological surveys on animal arboviruses in Central Africa (horse sickness, blue tongue, Wesselsbron's disease, Rift Valley fever) |
| Q27488442 | Serological tests for detecting Rift Valley fever viral antibodies in sheep from the Nile Delta |
| Q40318779 | Seroprevalence of 2 zoonotic diseases in Southwestern Saudi Arabia. Rift Valley fever and brucellosis. |
| Q35692609 | Seroprevalence of Infections with Dengue, Rift Valley Fever and Chikungunya Viruses in Kenya, 2007 |
| Q47549408 | Seroprevalence of Rift Valley Fever Virus Antibodies in Cattle in Mali, 2005-2014. |
| Q38997594 | Seroprevalence of Rift Valley fever and lumpy skin disease in African buffalo (Syncerus caffer) in the Kruger National Park and Hluhluwe-iMfolozi Park, South Africa |
| Q38940396 | Seroprevalence of Rift Valley fever in cattle along the Akagera-Nyabarongo rivers, Rwanda |
| Q36337127 | Seroprevalence of Rift Valley fever virus in livestock during inter-epidemic period in Egypt, 2014/15. |
| Q37067311 | Seroprevalence of Rift Valley fever virus in sheep and goats in Zambézia, Mozambique |
| Q39501218 | Seroprevalence of Rift Valley fever virus infection in camels (dromedaries) in northern Tanzania |
| Q40186451 | Seroprevalence of Rift Valley fever, Q fever, and brucellosis in ruminants on the southeastern shore of Lake Chad |
| Q35804998 | Seroprevalence of Sheep and Goat Pox, Peste Des Petits Ruminants and Rift Valley Fever in Saudi Arabia |
| Q24629283 | Seroprevalence of antibodies against Chikungunya, Dengue, and Rift Valley fever viruses after febrile illness outbreak, Madagascar |
| Q40666023 | Serum antibody to Rift Valley fever virus in African carnivores |
| Q36127490 | Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease |
| Q33436753 | Severe Human Illness Caused by Rift Valley Fever Virus in Mauritania, 2015 |
| Q33693574 | Severe Rift Valley fever may present with a characteristic clinical syndrome |
| Q40158097 | Severe hemorrhagic form of Rift Valley Fever in Mauritania |
| Q40334980 | Severe presentations of Rift Valley Fever in Madagascar |
| Q34469994 | Sheep skin odor improves trap captures of mosquito vectors of Rift Valley fever |
| Q37433779 | Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells |
| Q39007763 | Short report: Rift Valley fever in western Africa: isolations from Aedes mosquitoes during an interepizootic period |
| Q40450475 | Short report: efficient oral infection of Culex pipiens quinquefasciatus by Rift Valley fever virus using a cotton stick support. |
| Q34258654 | Simulation modelling of population dynamics of mosquito vectors for rift valley Fever virus in a disease epidemic setting |
| Q35066988 | Simultaneous detection of Rift Valley Fever, bluetongue, rinderpest, and Peste des petits ruminants viruses by a single-tube multiplex reverse transcriptase-PCR assay using a dual-priming oligonucleotide system |
| Q36109044 | Single-Molecule FISH Reveals Non-selective Packaging of Rift Valley Fever Virus Genome Segments |
| Q36326847 | Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates |
| Q35868079 | Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge |
| Q37673160 | Single-dose intranasal treatment with DEF201 (adenovirus vectored consensus interferon) prevents lethal disease due to Rift Valley fever virus challenge |
| Q27488344 | Single-particle cryo-electron microscopy of Rift Valley fever virus |
| Q40609304 | Single-tube and nested reverse transcriptase-polymerase chain reaction for detection of Rift Valley fever virus in human and animal sera |
| Q37300854 | Socio-economic impact of Rift Valley fever to pastoralists and agro pastoralists in Arusha, Manyara and Morogoro regions in Tanzania |
| Q27488299 | Solid-phase immunosorbent technique for rapid detection of Rift Valley fever virus immunoglobulin M by hemagglutination inhibition |
| Q38631743 | Sorafenib impedes Rift Valley fever virus egress by inhibiting Valosin-containing protein function in the cellular secretory pathway |
| Q27468611 | Spatial Heterogeneity of Habitat Suitability for Rift Valley Fever Occurrence in Tanzania: An Ecological Niche Modelling Approach |
| Q35106416 | Spatial and temporal pattern of Rift Valley fever outbreaks in Tanzania; 1930 to 2007. |
| Q40444693 | Spatial risk assessment of Rift Valley fever in Senegal |
| Q30855605 | Spatial, seasonal and climatic predictive models of Rift Valley fever disease across Africa. |
| Q28603957 | Spatio-temporal variation in prevalence of Rift Valley fever: a post-epidemic serum survey in cattle and wildlife in Kenya |
| Q35763790 | Species Diversity, Abundance, and Host Preferences of Mosquitoes (Diptera: Culicidae) in Two Different Ecotypes of Madagascar With Recent RVFV Transmission |
| Q36632198 | Spectrum of Rift Valley fever virus transmission in Kenya: insights from three distinct regions. |
| Q45894467 | Spread of Rift Valley fever virus from continental Africa |
| Q33792385 | Stability of Rift Valley fever virus at 4 C |
| Q40275529 | Stability of a formalin-inactivated Rift Valley fever vaccine: evaluation of a vaccination campaign for cattle in Mozambique |
| Q34278268 | Stability, bifurcation and chaos analysis of vector-borne disease model with application to Rift Valley fever |
| Q28650806 | Statistical modeling of the abundance of vectors of West African Rift Valley fever in Barkédji, Senegal |
| Q39368701 | Structural and Practical Identifiability Issues of Immuno-Epidemiological Vector-Host Models with Application to Rift Valley Fever |
| Q27662293 | Structure of the Rift Valley fever virus nucleocapsid protein reveals another architecture for RNA encapsidation |
| Q46875187 | Studies on Neurotropic Rift Valley Fever Virus: The Susceptibility of Rodents |
| Q27482975 | Studies on Rift Valley fever in some African murids (Rodentia: Muridae) |
| Q39173750 | Studies on Rift Valley fever in the domestic animals in Egypt |
| Q41012644 | Studies on arthropod-borne viruses of Tongaland. V. Isolation of Bunyamwera and Rift Valley Fever viruses from mosquitoes |
| Q40889920 | Studies on the epidemiology of Rift Valley Fever |
| Q40436634 | Study on DNA immune of envelope protein gene of Rift Valley Fever Virus |
| Q31037099 | Surveillance of Rift Valley Fever Virus in Mosquito Vectors of the Republic of Korea. |
| Q40156739 | Survey of investigation around cases of Rift Valley Fever at Tagant, Mauritania |
| Q38984861 | Susceptibility of CER cell line to Rift Valley Fever virus |
| Q40919565 | Susceptibility of dogs and cats to Rift Valley fever by inhalation or ingestion of virus |
| Q42987348 | Susceptibility of selected strains of Australian mosquitoes (Diptera: Culicidae) to Rift Valley fever virus |
| Q40233812 | Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins |
| Q39946457 | T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus |
| Q33198557 | TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. |
| Q40980838 | THE EFFECT OF RECENTLY ISOLATED STRAINS OF RIFT VALLEY FEVER VIRUS ON LAMB TESTIS CELL CULTURES. |
| Q40969004 | TITRATION OF RIFT VALLEY FEVER VIRUS IN HAMSTER KIDNEY CELLS IN THE ABSENCE OF SERUM |
| Q35679057 | Targeting TFIIH to inhibit host cell transcription by Rift Valley Fever Virus |
| Q26796199 | Temperature-sensitive mutations for live-attenuated Rift Valley fever vaccines: implications from other RNA viruses |
| Q44936397 | Tempering the risk: Rift Valley fever and bioterrorism |
| Q38110340 | Temporal and spatial history of Rift Valley fever in South Africa: 1950 to 2011. |
| Q34086918 | Temporal distribution and spatial pattern of abundance of the Rift Valley fever and West Nile fever vectors in Barkedji, Senegal |
| Q40579610 | Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep. |
| Q39560531 | TerraSAR-X high-resolution radar remote sensing: an operational warning system for Rift Valley fever risk. |
| Q33961482 | The 2000 epidemic of Rift Valley fever in Saudi Arabia: mosquito vector studies |
| Q39446749 | The 2006-2007 Rift Valley fever outbreak in Kenya: sources of early warning messages and response measures implemented by the Department of Veterinary Services |
| Q27026883 | The 2007 Rift Valley fever outbreak in Sudan |
| Q36506825 | The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts antiapoptotic function |
| Q40935546 | The Clinical Aspects of Rift Valley Fever Virus in Household Pets.: I. Susceptibility of the Dog |
| Q40935256 | The Clinical Aspects of Rift Valley Fever Virus in Household Pets.: III. Pathologic Changes in the Dog and Cat |
| Q40935264 | The Clinical Aspects of Rift Valley Fever Virus in Household Pets: II. Susceptibility of the Cat |
| Q40784119 | The Distribution of Rift Valley Fever Virus in the Mosquito Culex Pipiens as Revealed by Viral Titration of Dissected Organs and Tissues |
| Q26315278 | The Epidemiology of Rift Valley Fever in Mayotte: Insights and Perspectives from 11 Years of Data |
| Q34034064 | The Historical and Recent Impact of Rift Valley Fever in Africa |
| Q40951894 | The Immunity Induced in Cattle and Sheep by Inoculation of Neurotropic or Pantropic Rift Valley Fever Viruses |
| Q39870549 | The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules |
| Q36694012 | The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype |
| Q47116359 | The Mechanism of Immunity in Rift Valley Fever |
| Q40499509 | The N terminus of Rift Valley fever virus nucleoprotein is essential for dimerization |
| Q27485926 | The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection |
| Q36283074 | The One Health approach to identify knowledge, attitudes and practices that affect community involvement in the control of Rift Valley fever outbreaks |
| Q34354086 | The Rift Valley Fever virus protein NSm and putative cellular protein interactions |
| Q34440401 | The Rift Valley fever accessory proteins NSm and P78/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts |
| Q39240187 | The Rift Valley fever epizootic in Egypt 1977–1978 1. Description of the epizootic and virological studies |
| Q39076413 | The Rift Valley fever epizootic in Egypt 1977–1978 2. Ecological and entomological studies |
| Q40630761 | The Rift Valley fever virus nonstructural protein NSs is phosphorylated at serine residues located in casein kinase II consensus motifs in the carboxy-terminus |
| Q40878566 | The Rift Valley fever virus, agent of dengue-like epidemics: its geographical distribution and public health problems |
| Q38986329 | The Rift Valley fever: could re-emerge in Egypt again? |
| Q35875622 | The Risk of Nosocomial Transmission of Rift Valley Fever |
| Q40093035 | The Role of Hyalomma Truncatum on the Dynamics of Rift Valley Fever: Insights from a Mathematical Epidemic Model |
| Q39588385 | The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice |
| Q46652368 | The Sudan dioch (Quelea quelea aethiopica) and Rift Valley fever |
| Q41021120 | The antiviral activity of acridines in eastern equine encephalomyelitis, Rift Valley fever and psittacosis in mice, and lymphogranuloma venereum in chick-embryos |
| Q27469709 | The carboxy-terminal acidic domain of Rift Valley Fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein. |
| Q38912744 | The clinical picture of Rift Valley fever in Egypt |
| Q40740013 | The clinico-epidemiological aspects of a study of Rift Valley fever |
| Q41021091 | The coagulation defect in Rift Valley fever and yellow fever virus infections. |
| Q35097103 | The consequences of reconfiguring the ambisense S genome segment of Rift Valley fever virus on viral replication in mammalian and mosquito cells and for genome packaging |
| Q40987065 | The development of a formalin-killed Rift Valley fever virus vaccine for use in man. |
| Q41065007 | The development of neurotropism in Rift Valley fever virus |
| Q36155392 | The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine |
| Q40144461 | The effect of Rift Valley fever virus Clone 13 vaccine on semen quality in rams. |
| Q39017952 | The effect of laboratory colonization on the vector-pathogen interactions of Egyptian Culex pipiens and Rift Valley fever virus |
| Q30416792 | The effect of neutralizing monoclonal antibodies on early events in Rift Valley fever virus infectivity |
| Q40743205 | The efficacy of immobilized liposomal preparations of ribamidil in experimental Rift Valley fever |
| Q38642136 | The epidemiology and socio-economic impact of rift valley fever epidemics in Tanzania: a review |
| Q39193274 | The evolving transmission pattern of Rift Valley fever in the Arabian Peninsula. |
| Q40864332 | The extended horizons of Rift Valley fever: current and projected immunogens. |
| Q41021005 | The fevers of Africa. III. Rift Valley Fever |
| Q37617638 | The first imported case of Rift Valley fever in China reveals a genetic reassortment of different viral lineages |
| Q49819027 | The first positive serological study on rift valley fever in ruminants of Iran |
| Q39201576 | The first serological evidence for Rift Valley fever infection in the camel, goitered gazelle and Anatolian water buffaloes in Turkey |
| Q40790822 | The gerbil, Meriones unguiculatus, a model for Rift Valley fever viral encephalitis |
| Q27311874 | The hexamer structure of Rift Valley fever virus nucleoprotein suggests a mechanism for its assembly into ribonucleoprotein complexes |
| Q40781526 | The horizontal distribution of Aedes pupae and their subsequent adults within a flooded dambo in Kenya: implications for Rift Valley fever virus control |
| Q33372240 | The impact of climate change on the epidemiology and control of Rift Valley fever. |
| Q40306367 | The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus |
| Q34634852 | The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses |
| Q40989584 | The pathogenesis of Rift Valley fever in lambs |
| Q40348320 | The pathogenesis of Rift Valley fever virus in the mouse model |
| Q40921346 | The pathogenicity of rift valley fever virus for the baboon |
| Q40879284 | The pathology of Rift Valley fever. I. Lesions occurring in natural cases in new-born lambs |
| Q40845919 | The pathology of Rift Valley fever. II. Lesions occurring in field cases in adult cattle, calves and aborted foetuses |
| Q40455262 | The persistence of rift valley fever in the Jazan region of Saudi Arabia. |
| Q39618675 | The potential role of Rattus rattus in enzootic cycle of Rift Valley Fever in Egypt. 1-Detection of RVF antibodies in R. rattus blood samples by both enzyme linked immuno sorbent assay (ELISA) and immuno-diffusion technique (ID). |
| Q40374851 | The potential role of pigs in the enzootic cycle of rift valley Fever at alexandria governorate, egyp |
| Q39618663 | The potential role of rattus rattus in enzootic cycle of Rift Valley Fever in Egypt 2-application of reverse transcriptase polymerase chain reaction (RT-PCR) in blood samples of Rattus rattus |
| Q40621269 | The potential role of rodents in the enzootic cycle of Rift Valley fever virus in Senegal |
| Q27490821 | The prevalence of antibody to the viruses of bovine virus diarrhoea, bovine herpes virus 1, rift valley fever, ephemeral fever and bluetongue and to Leptospira sp in free-ranging wildlife in Zimbabwe |
| Q37433782 | The risk of Rift Valley fever virus introduction and establishment in the United States and European Union |
| Q39672712 | The role of signal transducer and activator of transcription 3 in Rift Valley fever virus infection |
| Q38001682 | The role of wild mammals in the maintenance of Rift Valley fever virus |
| Q38689369 | The sero-epidemiology of Rift Valley fever in people in the Lake Victoria Basin of western Kenya. |
| Q40984275 | The serological reactions in a case of Rift Valley fever. |
| Q27486837 | The spread of Rift Valley fever and approaches to its control |
| Q30224987 | The status of Rift Valley fever in animals in Saudi Arabia: a mini review |
| Q40847113 | The susceptibility of Culicoides variipennis Coq. (Diptera: Ceratopogonidae) to laboratory infection with Rift Valley fever virus |
| Q41048960 | The susceptibility of rats to Rift Valley fever in relation to age. |
| Q40738802 | The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins |
| Q37071493 | The transmission potential of Rift Valley fever virus among livestock in the Netherlands: a modelling study |
| Q37509231 | The two faces of Rift Valley fever virus virulence factor NSs: The development of a vaccine and the elucidation of pathogenesis |
| Q34828833 | The use of NanoTrap particles as a sample enrichment method to enhance the detection of Rift Valley Fever Virus |
| Q35644546 | The use of Nanotrap particles in the enhanced detection of Rift Valley fever virus nucleoprotein |
| Q40677165 | The use of sucrose-acetone-extracted Rift Valley fever virus antigen derived from cell culture in an indirect enzyme-linked immunosorbent assay and haemagglutination-inhibition test |
| Q27486846 | The use of veterinary vaccines for prevention and control of Rift Valley fever: memorandum from a WHO/FAO meeting |
| Q27487138 | Three-Dimensional Organization of Rift Valley Fever Virus Revealed by Cryoelectron Tomography |
| Q34097995 | Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice. |
| Q40755091 | Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies |
| Q34677989 | Towards a safe, effective vaccine for Rift Valley fever virus |
| Q36542318 | Transmission Dynamics of Rift Valley Fever Virus: Effects of Live and Killed Vaccines on Epizootic Outbreaks and Enzootic Maintenance |
| Q40755728 | Transmission of Rift Valley fever virus by adult mosquitoes after ingestion of virus as larvae |
| Q39015037 | Transmission of Rift Valley fever virus by different geographic strains of Culex pipiens in Egypt |
| Q40765222 | Transmission of Rift Valley fever virus by the sand fly, Phlebotomus duboscqi (Diptera: Psychodidae). |
| Q47560206 | Transmission of Rift Valley fever virus from European-breed lambs to Culex pipiens mosquitoes. |
| Q37020531 | Transmission potential of Rift Valley fever virus over the course of the 2010 epidemic in South Africa. |
| Q40802503 | Transmission studies in mosquitoes (Diptera: Culicidae) with disseminated Rift Valley fever virus infections |
| Q40770401 | Transstadial and horizontal transmission of Rift Valley fever virus in Hyalomma truncatum |
| Q36124675 | Trapping of Rift Valley Fever (RVF) vectors using light emitting diode (LED) CDC traps in two arboviral disease hot spots in Kenya |
| Q40715732 | Ultrafiltration as a Method for Concentrating Rift Valley Fever Virus Grown in Tissue Culture |
| Q40094330 | Ultrastructural pathology of human liver in Rift Valley fever |
| Q40283964 | Ultrastructural study of Rift Valley fever virus in the mouse model |
| Q38366135 | Understanding Rift Valley fever: contributions of animal models to disease characterization and control |
| Q47551287 | Understanding the legal trade of cattle and camels and the derived risk of Rift Valley Fever introduction into and transmission within Egypt. |
| Q35847618 | Unexpected Rift Valley fever outbreak, northern Mauritania |
| Q39192580 | Update: outbreak of Rift Valley Fever--Saudi Arabia, August-November 2000. |
| Q35041237 | Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus |
| Q40397965 | Use of insecticide-treated cattle to control Rift Valley fever and West Nile virus vectors in Senegal |
| Q40759549 | Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine |
| Q39625707 | Use of reverse transcriptase PCR in early diagnosis of Rift Valley fever |
| Q40805522 | Use of the avidin-biotin-peroxidase complex immunocytochemical procedure for detection of Rift Valley fever virus in paraffin sections of mosquitoes |
| Q27486842 | Use of veterinary vaccines for preventing and combatting Rift Valley fever: memorandum of a WHO/FAO meeting |
| Q37156824 | Using a field quantitative real-time PCR test to rapidly identify highly viremic rift valley fever cases |
| Q35841573 | Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy |
| Q40247216 | Vaccination for the control of Rift Valley fever in enzootic and epizootic situations |
| Q39066685 | Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine. |
| Q33617793 | Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus |
| Q40399200 | Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus |
| Q40516521 | Validation of IgG-sandwich and IgM-capture ELISA for the detection of antibody to Rift Valley fever virus in humans |
| Q40169190 | Validation of an ELISA for the concurrent detection of total antibodies (IgM and IgG) to Rift Valley fever virus. |
| Q40315842 | Validation of an IgM antibody capture ELISA based on a recombinant nucleoprotein for identification of domestic ruminants infected with Rift Valley fever virus |
| Q40443895 | Validation of an indirect ELISA based on a recombinant nucleocapsid protein of Rift Valley fever virus for the detection of IgG antibody in humans |
| Q40644903 | Variability of the NS(S) protein among Rift Valley fever virus isolates |
| Q40784948 | Vector Competence of Senegalese Aedes fowleri (Diptera: Culicidae) for Rift Valley Fever Virus1 |
| Q36599998 | Vector competence of Aedes vexans (Meigen), Culex poicilipes (Theobald) and Cx. quinquefasciatus Say from Senegal for West and East African lineages of Rift Valley fever virus |
| Q47547724 | Vector competence of Culex antennatus and Anopheles coustani mosquitoes for Rift Valley fever virus in Madagascar. |
| Q34377721 | Vector competence of Egyptian mosquitoes for Rift Valley fever virus. |
| Q34744033 | Vector competence of Kenyan Culex zombaensis and Culex quinquefasciatus mosquitoes for Rift Valley fever virus |
| Q40788176 | Vector competence of a Houston, Texas strain of Aedes albopictus for Rift Valley fever virus |
| Q39195232 | Vector competence of selected African mosquito (Diptera: Culicidae) species for Rift Valley fever virus |
| Q40788331 | Vector competence tests with Rift Valley fever virus and five South African species of mosquito |
| Q40788381 | Vector potential of selected North American mosquito species for Rift Valley fever virus |
| Q40860033 | Vector studies on Rift Valley Fever virus in South Africa |
| Q40247447 | Vertical transmission of Rift Valley fever virus without detectable maternal viremia |
| Q40471715 | Vertical transmission of fatal Rift Valley fever in a newborn. |
| Q40265879 | Viral Immunofluorescence with Rift Valley Fever Virus Infected MEFs in a 96 Well Plate. |
| Q40782624 | Viral determinants of virulence for Rift Valley fever (RVF) in rats |
| Q39240201 | Viral studies of Rift Valley fever in the Arab Republic of Egypt |
| Q38326807 | Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH |
| Q40878515 | Virus isolation and identification from cases of Rift Valley fever virus infection in Egypt |
| Q39044207 | Virus isolations and high population density implicate Culex antennatus (Becker) (Diptera: Culicidae) as a vector of Rift Valley Fever virus during an outbreak in the Nile Delta of Egypt |
| Q40730162 | Virus-dependent mortality in Rift Valley fever, eastern equine encephalomyelitis, and chikungunya virus-inoculated mosquito (Diptera: Culicidae) larvae |
| Q40254473 | Virus-like particle-based countermeasures against Rift Valley fever virus |
| Q39653963 | Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus |
| Q38662188 | Wetlands, wild Bovidae species richness and sheep density delineate risk of Rift Valley fever outbreaks in the African continent and Arabian Peninsula. |
| Q39526935 | Wicking assay for the rapid detection of Rift Valley fever viral antigens in mosquitoes (Diptera: Culicidae). |
| Q27468927 | Widespread Rift Valley Fever Emergence in Senegal in 2013–2014 |
| Q44169412 | Wolbachia effects on Rift Valley fever virus infection in Culex tarsalis mosquitoes |
| Q40837874 | Zinga virus: a strain of Rift Valley fever virus |
| Q40454400 | [El niño and its consequences: outbreak of Rift Valley fever in Kenya]. |
| Q40464580 | [Feeding pattern of Rift Valley Fever virus vectors in Senegal. Implications in the disease epidemiology] |
| Q40829138 | [Rift Valley fever] |
| Q24319790 | p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production |
